// ODIN Mobile — Upcoming Catalyst Data
// Extracted from pdufa.bio scoring engine

import { Catalyst } from './types';

export const CATALYSTS_DATA: Catalyst[] = [
  {
    id: 'vnda-bysanti-2026-02-21',
    date: '2026-02-21',
    company: 'Vanda Pharmaceuticals',
    ticker: 'VNDA',
    drug: 'Bysanti (milsaperidone)',
    indication: 'Schizophrenia / Bipolar-I',
    type: 'PDUFA',
    appType: 'NDA',
    ta: 'CNS',
    phase: 'Phase 3',
    designations: [],
    prob: 0.3959,
    tier: 'TIER_4',
    signals: {
      'inexperienced_sponsor': -1.2875,
      'ta_mod_risk': -0.1809,
      'me_too': -0.35
    },
  },
  {
    id: 'otsuka-inqovi-venetoclax-2026-02-25',
    date: '2026-02-25',
    company: 'Otsuka',
    ticker: 'OTSKF',
    drug: 'INQOVI + Venetoclax',
    indication: 'Acute Myeloid Leukemia',
    type: 'PDUFA',
    appType: 'sNDA',
    ta: 'Oncology',
    phase: 'Phase 3',
    designations: [],
    prob: 0.8556,
    tier: 'TIER_1',
    signals: {
      'sNDA/sBLA': -0.441,
      'experienced_sponsor': 0.9387,
      'ta_low_risk': 0.0838,
      'ind_cancer': 0.2523,
      'single_arm_pivotal': -0.55,
      'division_favorable': 0.1
    },
  },
  {
    id: 'regn-dupixent-afrs-2026-02-28',
    date: '2026-02-28',
    company: 'Regeneron / Sanofi',
    ticker: 'REGN',
    drug: 'Dupixent',
    indication: 'Allergic Fungal Rhinosinusitis',
    type: 'PDUFA',
    appType: 'sBLA',
    ta: 'Immunology',
    phase: 'Phase 3',
    designations: ['Priority Review'],
    prob: 0.9304,
    tier: 'TIER_1',
    signals: {
      'sNDA/sBLA': -0.441,
      'priority_review': 0.615,
      'experienced_sponsor': 0.9387,
      'ta_low_risk': 0.0838
    },
  },
  {
    id: 'asnd-navepegritide-2026-02-28',
    date: '2026-02-28',
    company: 'Ascendis Pharma',
    ticker: 'ASND',
    drug: 'Navepegritide (TransCon CNP)',
    indication: 'Achondroplasia',
    type: 'PDUFA',
    appType: 'BLA',
    ta: 'Rare Disease',
    phase: 'Phase 3',
    designations: ['Orphan Drug', 'Priority Review'],
    prob: 0.9554,
    tier: 'TIER_1',
    signals: {
      'experienced_sponsor': 0.9387,
      'orphan': 0.1469,
      'priority_review': 0.615,
      'primary_endpoint_met': 0.45,
      'ta_mod_risk': -0.1809,
      'me_too': -0.35,
      'pdufa_extension': -0.15,
      'fda_no_adcom_required': 0.2
    },
  },
  {
    id: 'bmy-deucravacitinib-2026-03-06',
    date: '2026-03-06',
    company: 'Bristol-Myers Squibb',
    ticker: 'BMY',
    drug: 'Deucravacitinib (Sotyktu)',
    indication: 'Psoriatic Arthritis',
    type: 'PDUFA',
    appType: 'sNDA',
    ta: 'Immunology',
    phase: 'Phase 3',
    designations: [],
    prob: 0.8887,
    tier: 'TIER_1',
    signals: {
      'sNDA/sBLA': -0.441,
      'experienced_sponsor': 0.9387,
      'ta_low_risk': 0.0838,
      'division_favorable': 0.1
    },
  },
  {
    id: 'aldx-reproxalap-2026-03-16',
    date: '2026-03-16',
    company: 'Aldeyra Therapeutics',
    ticker: 'ALDX',
    drug: 'Reproxalap',
    indication: 'Dry Eye Disease',
    type: 'PDUFA',
    appType: 'NDA',
    ta: 'Ophthalmology',
    phase: 'Phase 3',
    designations: [],
    prob: 0.011,
    tier: 'TIER_4',
    signals: {
      'prior_CRL': -3.3533,
      'resubmission_post_CRL': 2.0,
      'serial_crl_penalty': -0.50,
      'inexperienced_sponsor': -1.2875,
      'hist_crl_rate': -1.4953,
      'ta_high_risk': -0.2555,
      'novice_high_risk_ta': -0.4071,
      'surrogate_only': -0.45,
      'me_too': -0.35,
      'fda_no_adcom_required': 0.2
    },
  },
  {
    id: 'rytm-imcivree-2026-03-20',
    date: '2026-03-20',
    company: 'Rhythm Pharmaceuticals',
    ticker: 'RYTM',
    drug: 'Imcivree (setmelanotide)',
    indication: 'Acquired Hypothalamic Obesity',
    type: 'PDUFA',
    appType: 'sNDA',
    ta: 'Metabolic/Endocrine',
    phase: 'Phase 3',
    designations: ['Orphan Drug'],
    prob: 0.5208,
    tier: 'TIER_4',
    signals: {
      'sNDA/sBLA': -0.441,
      'inexperienced_sponsor': -1.2875,
      'orphan': 0.1469,
      'ta_mod_risk': -0.1809,
      'first_in_class': 0.45
    },
  },
  {
    id: 'gsk-linerixibat-2026-03-24',
    date: '2026-03-24',
    company: 'GSK',
    ticker: 'GSK',
    drug: 'Linerixibat',
    indication: 'Cholestatic Pruritus (PBC)',
    type: 'PDUFA',
    appType: 'NDA',
    ta: 'GI/Hepatology',
    phase: 'Phase 3',
    designations: [],
    prob: 0.9656,
    tier: 'TIER_1',
    signals: {
      'experienced_sponsor': 0.9387,
      'first_in_class': 0.45,
      'unmet_need': 0.55
    },
  },
  {
    id: 'lly-orforglipron-2026-03-25',
    date: '2026-03-25',
    company: 'Eli Lilly',
    ticker: 'LLY',
    drug: 'Orforglipron',
    indication: 'Type 2 Diabetes / Obesity',
    type: 'PDUFA',
    appType: 'NDA',
    ta: 'Metabolic/Endocrine',
    phase: 'Phase 3',
    designations: ['National Priority Voucher'],
    prob: 0.9615,
    tier: 'TIER_1',
    signals: {
      'priority_review': 0.615,
      'experienced_sponsor': 0.9387,
      'ta_mod_risk': -0.1809,
      'first_in_class': 0.45
    },
  },
  // IRON/Bitopertin REMOVED — received CRL on Feb 13, 2026
  // FDA cited insufficient evidence of clinical benefit despite biomarker improvement
  // ODIN correctly scored TIER_4 (35.7%) — moved to verified track record
  {
    id: 'rckt-kresladi-2026-03-28',
    date: '2026-03-28',
    company: 'Rocket Pharmaceuticals',
    ticker: 'RCKT',
    drug: 'Kresladi (marnetegragene autotemcel)',
    indication: 'Leukocyte Adhesion Deficiency-I',
    type: 'PDUFA',
    appType: 'BLA',
    ta: 'Rare Disease',
    phase: 'Phase 1/2',
    designations: ['Orphan Drug', 'Breakthrough Therapy', 'Priority Review'],
    prob: 0.3088,
    tier: 'TIER_4',
    signals: {
      'inexperienced_sponsor': -1.2875,
      'BTD': 0.1676,
      'orphan': 0.1469,
      'priority_review': 0.615,
      'class1_resub': 0.57,
      'manufacturing_risk': -1.0589,
      'cmc_extension': -0.9845,
      'single_arm_pivotal': -0.55,
      'small_pivotal_n': -0.4,
      'first_in_class': 0.45,
      'unmet_need': 0.55,
      'interaction_inexperienced_mfg': -0.5,
      'cber_advanced_therapy': -0.12,
      'social_positive': 0.2
    },
  },
  {
    id: 'lnth-ga68-edotreotide-2026-03-29',
    date: '2026-03-29',
    company: 'Lantheus',
    ticker: 'LNTH',
    drug: 'Gallium-68 edotreotide',
    indication: 'NET PET Imaging',
    type: 'PDUFA',
    appType: 'NDA',
    ta: 'Oncology',
    phase: 'Phase 3',
    designations: [],
    prob: 0.8291,
    tier: 'TIER_2',
    signals: {
      'ta_low_risk': 0.0838,
      'division_favorable': 0.1
    },
  },
  {
    id: 'dnli-tividenofusp-2026-04-05',
    date: '2026-04-05',
    company: 'Denali Therapeutics',
    ticker: 'DNLI',
    drug: 'Tividenofusp alfa',
    indication: 'Hunter Syndrome (MPS II)',
    type: 'PDUFA',
    appType: 'BLA',
    ta: 'Rare Disease',
    phase: 'Phase 2/3',
    designations: ['Breakthrough Therapy', 'Orphan Drug', 'Priority Review'],
    prob: 0.1383,
    tier: 'TIER_4',
    signals: {
      'inexperienced_sponsor': -1.2875,
      'BTD': 0.1676,
      'orphan': 0.1469,
      'priority_review': 0.615,
      'cmc_extension': -0.9845,
      's22_pediatric_pk': -1.9328,
      'surrogate_only': -0.45,
      'first_in_class': 0.45,
      'unmet_need': 0.55,
      'interaction_inexperienced_mfg': -0.5
    },
  },
  {
    id: 'orca-orca-t-2026-04-06',
    date: '2026-04-06',
    company: 'Orca Bio',
    ticker: 'ORCA',
    drug: 'Orca-T',
    indication: 'Hematologic Malignancies (AML/ALL/MDS)',
    type: 'PDUFA',
    appType: 'BLA',
    ta: 'Oncology',
    phase: 'Phase 3',
    designations: ['Priority Review'],
    prob: 0.8438,
    tier: 'TIER_2',
    signals: {
      'inexperienced_sponsor': -1.2875,
      'priority_review': 0.615,
      'ta_low_risk': 0.0838,
      'first_in_class': 0.45,
      'unmet_need': 0.55,
      'cber_advanced_therapy': -0.12
    },
  },
  {
    id: 'tvtx-sparsentan-2026-04-13',
    date: '2026-04-13',
    company: 'Travere Therapeutics',
    ticker: 'TVTX',
    drug: 'Sparsentan',
    indication: 'Focal Segmental Glomerulosclerosis (FSGS)',
    type: 'PDUFA',
    appType: 'sNDA',
    ta: 'Nephrology',
    phase: 'Phase 3',
    designations: ['Priority Review', 'Accelerated Approval conversion'],
    prob: 0.1115,
    tier: 'TIER_4',
    signals: {
      'sNDA/sBLA': -0.441,
      'inexperienced_sponsor': -1.2875,
      'priority_review': 0.615,
      'accel_approval': 0.5552,
      'ta_high_risk': -0.2555,
      'novice_high_risk_ta': -0.4071,
      'primary_endpoint_missed': -1.8,
      'surrogate_only': -0.45
    },
  },
  {
    id: 'azn-baxdrostat-2026-05-15',
    date: '2026-05-15',
    company: 'AstraZeneca',
    ticker: 'AZN',
    drug: 'Baxdrostat',
    indication: 'Treatment-Resistant Hypertension',
    type: 'PDUFA',
    appType: 'NDA',
    ta: 'Cardiovascular',
    phase: 'Phase 3',
    designations: ['Priority Review'],
    prob: 0.9615,
    tier: 'TIER_1',
    signals: {
      'priority_review': 0.615,
      'experienced_sponsor': 0.9387,
      'ta_mod_risk': -0.1809,
      'first_in_class': 0.45
    },
  },
  {
    id: 'aclx-cytisinicline-2026-06-20',
    date: '2026-06-20',
    company: 'Achieve Life Sciences',
    ticker: 'ACHV',
    drug: 'Cytisinicline',
    indication: 'Smoking Cessation',
    type: 'PDUFA',
    appType: 'NDA',
    ta: 'CNS',
    phase: 'Phase 3',
    designations: ['Breakthrough Therapy'],
    prob: 0.3522,
    tier: 'TIER_4',
    signals: {
      'inexperienced_sponsor': -1.2875,
      'BTD': 0.1676,
      'ta_mod_risk': -0.1809,
      'indication_pain': -0.3546,
      'me_too': -0.35
    },
  },
  {
    id: 'vrdn-veligrotug-2026-06-30',
    date: '2026-06-30',
    company: 'Viridian Therapeutics',
    ticker: 'VRDN',
    drug: 'Veligrotug',
    indication: 'Thyroid Eye Disease',
    type: 'PDUFA',
    appType: 'BLA',
    ta: 'Immunology',
    phase: 'Phase 3',
    designations: ['Priority Review'],
    prob: 0.7785,
    tier: 'TIER_2',
    signals: {
      'inexperienced_sponsor': -1.2875,
      'priority_review': 0.615,
      'ta_low_risk': 0.0838,
      'first_in_class': 0.45
    },
  },
  {
    id: 'kura-tipifarnib-2026-07-01',
    date: '2026-07-01',
    company: 'Kura Oncology',
    ticker: 'KURA',
    drug: 'Tipifarnib',
    indication: 'HRAS-mutant HNSCC',
    type: 'PDUFA',
    appType: 'NDA',
    ta: 'Oncology',
    phase: 'Phase 2',
    designations: ['Breakthrough Therapy', 'Orphan Drug', 'Priority Review'],
    prob: 0.9022,
    tier: 'TIER_1',
    signals: {
      'inexperienced_sponsor': -1.2875,
      'BTD': 0.1676,
      'orphan': 0.1469,
      'priority_review': 0.615,
      'ta_low_risk': 0.0838,
      'first_in_class': 0.45,
      'unmet_need': 0.55,
      'division_favorable': 0.1
    },
  },
  {
    id: 'gsk-varicella-vaccine-2026-07-01',
    date: '2026-07-01',
    company: 'GSK',
    ticker: 'GSK',
    drug: 'Varicella vaccine (investigational)',
    indication: 'Chickenpox',
    type: 'READOUT',
    appType: '',
    ta: 'Vaccines',
    phase: 'Phase 3',
    designations: [],
    prob: 0.9194,
    tier: 'TIER_1',
    signals: {
      'experienced_sponsor': 0.9387,
      'division_favorable': 0.1
    },
  },
  {
    id: 'mrk-pembrolizumab-combos-2026-07-06',
    date: '2026-07-06',
    company: 'Merck',
    ticker: 'MRK',
    drug: 'Pembrolizumab combos',
    indication: 'Lung Cancer (multiple trials)',
    type: 'READOUT',
    appType: '',
    ta: 'Oncology',
    phase: 'Phase 3',
    designations: [],
    prob: 0.9411,
    tier: 'TIER_1',
    signals: {
      'experienced_sponsor': 0.9387,
      'ta_low_risk': 0.0838,
      'ind_cancer': 0.2523,
      'division_favorable': 0.1
    },
  },
  {
    id: 'vera-atacicept-2026-07-07',
    date: '2026-07-07',
    company: 'Vera Therapeutics',
    ticker: 'VERA',
    drug: 'Atacicept',
    indication: 'IgA Nephropathy',
    type: 'PDUFA',
    appType: 'BLA',
    ta: 'Nephrology',
    phase: 'Phase 3',
    designations: ['Breakthrough Therapy', 'Orphan Drug'],
    prob: 0.7232,
    tier: 'TIER_2',
    signals: {
      'inexperienced_sponsor': -1.2875,
      'BTD': 0.1676,
      'orphan': 0.1469,
      'ta_high_risk': -0.2555,
      'novice_high_risk_ta': -0.4071,
      'first_in_class': 0.45,
      'unmet_need': 0.55,
      'social_positive': 0.2
    },
  },
  {
    id: 'regn-mibavademab-2026-07-14',
    date: '2026-07-14',
    company: 'Regeneron',
    ticker: 'REGN',
    drug: 'Mibavademab',
    indication: 'Generalized Lipodystrophy',
    type: 'READOUT',
    appType: '',
    ta: 'Rare Disease',
    phase: 'Phase 3',
    designations: [],
    prob: 0.9117,
    tier: 'TIER_1',
    signals: {
      'experienced_sponsor': 0.9387
    },
  },
  {
    id: 'azn-tezepelumab-2026-07-14',
    date: '2026-07-14',
    company: 'AstraZeneca',
    ticker: 'AZN',
    drug: 'Tezepelumab',
    indication: 'Eosinophilic Esophagitis',
    type: 'READOUT',
    appType: '',
    ta: 'GI/Hepatology',
    phase: 'Phase 3',
    designations: [],
    prob: 0.9117,
    tier: 'TIER_1',
    signals: {
      'experienced_sponsor': 0.9387
    },
  },
  {
    id: 'lly-lebrikizumab-2026-07-15',
    date: '2026-07-15',
    company: 'Eli Lilly',
    ticker: 'LLY',
    drug: 'Lebrikizumab',
    indication: 'Atopic Hand/Foot Dermatitis',
    type: 'READOUT',
    appType: '',
    ta: 'Dermatology',
    phase: 'Phase 3',
    designations: [],
    prob: 0.9254,
    tier: 'TIER_1',
    signals: {
      'experienced_sponsor': 0.9387,
      'ta_low_risk': 0.0838,
      'division_favorable': 0.1
    },
  },
  {
    id: 'hrmy-pitolisant-2026-07-15',
    date: '2026-07-15',
    company: 'Harmony Biosciences',
    ticker: 'HRMY',
    drug: 'Pitolisant',
    indication: 'Prader-Willi Syndrome',
    type: 'READOUT',
    appType: '',
    ta: 'CNS',
    phase: 'Phase 3',
    designations: [],
    prob: 0.0443,
    tier: 'TIER_4',
    signals: {
      'inexperienced_sponsor': -1.2875,
      'ta_mod_risk': -0.1809,
      'refused_to_file': -1.2,
      'primary_endpoint_missed': -1.8
    },
  },
  {
    id: 'lxrx-sotagliflozin-2026-07-15',
    date: '2026-07-15',
    company: 'Lexicon Pharmaceuticals',
    ticker: 'LXRX',
    drug: 'Sotagliflozin',
    indication: 'Hypertrophic Obstructive Cardiomyopathy',
    type: 'READOUT',
    appType: '',
    ta: 'Cardiovascular',
    phase: 'Phase 3',
    designations: [],
    prob: 0.5069,
    tier: 'TIER_4',
    signals: {
      'inexperienced_sponsor': -1.2875,
      'ta_mod_risk': -0.1809,
      'first_in_class': 0.45,
      'me_too': -0.35
    },
  },
  {
    id: 'rare-gtx-102-2026-07-15',
    date: '2026-07-15',
    company: 'Ultragenyx',
    ticker: 'RARE',
    drug: 'GTX-102',
    indication: 'Angelman Syndrome',
    type: 'READOUT',
    appType: '',
    ta: 'Rare Disease',
    phase: 'Phase 3',
    designations: [],
    prob: 0.7922,
    tier: 'TIER_2',
    signals: {
      'inexperienced_sponsor': -1.2875,
      'first_in_class': 0.45,
      'unmet_need': 0.55,
      'designation_stack': 0.35,
      'cber_advanced_therapy': -0.12
    },
  },
  {
    id: 'vrdn-vrdn-003-2026-07-15',
    date: '2026-07-15',
    company: 'Viridian Therapeutics',
    ticker: 'VRDN',
    drug: 'VRDN-003',
    indication: 'Thyroid Eye Disease',
    type: 'READOUT',
    appType: '',
    ta: 'Immunology',
    phase: 'Phase 3',
    designations: [],
    prob: 0.5725,
    tier: 'TIER_4',
    signals: {
      'inexperienced_sponsor': -1.2875,
      'ta_low_risk': 0.0838,
      'division_favorable': 0.1
    },
  },
  {
    id: 'mrk-tulisokibart-2026-08-01',
    date: '2026-08-01',
    company: 'Merck',
    ticker: 'MRK',
    drug: 'Tulisokibart (IV+SC)',
    indication: 'Ulcerative Colitis',
    type: 'READOUT',
    appType: '',
    ta: 'GI/Hepatology',
    phase: 'Phase 3',
    designations: [],
    prob: 0.9117,
    tier: 'TIER_1',
    signals: {
      'experienced_sponsor': 0.9387
    },
  },


  // ═══════════════════════════════════════════════════
  // EARNINGS DATES
  // ═══════════════════════════════════════════════════
  {
    id: 'vtgn-earnings-2026-02-12',
    date: '2026-02-12',
    company: 'Vistagen Therapeutics Inc.',
    ticker: 'VTGN',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'aemd-earnings-2026-02-12',
    date: '2026-02-12',
    company: 'Aethlon Medical Inc.',
    ticker: 'AEMD',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'bio-earnings-2026-02-12',
    date: '2026-02-12',
    company: 'Bio-Rad Laboratories Inc. Class A',
    ticker: 'BIO',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'plur-earnings-2026-02-12',
    date: '2026-02-12',
    company: 'Pluri Inc.',
    ticker: 'PLUR',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'aort-earnings-2026-02-12',
    date: '2026-02-12',
    company: 'Artivion Inc Com',
    ticker: 'AORT',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'cvrx-earnings-2026-02-12',
    date: '2026-02-12',
    company: 'CVRx Inc.',
    ticker: 'CVRX',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'pacb-earnings-2026-02-12',
    date: '2026-02-12',
    company: 'Pacific Biosciences of California Inc.',
    ticker: 'PACB',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'txg-earnings-2026-02-12',
    date: '2026-02-12',
    company: '10x Genomics Inc.',
    ticker: 'TXG',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'dxcm-earnings-2026-02-12',
    date: '2026-02-12',
    company: 'DexCom Inc.',
    ticker: 'DXCM',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'vrtx-earnings-2026-02-12',
    date: '2026-02-12',
    company: 'Vertex Pharmaceuticals Incorporated',
    ticker: 'VRTX',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'rare-earnings-2026-02-12',
    date: '2026-02-12',
    company: 'Ultragenyx Pharmaceutical Inc.',
    ticker: 'RARE',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'rcel-earnings-2026-02-12',
    date: '2026-02-12',
    company: 'Avita Medical Inc.',
    ticker: 'RCEL',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'crsp-earnings-2026-02-12',
    date: '2026-02-12',
    company: 'CRISPR Therapeutics AG',
    ticker: 'CRSP',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'aneb-earnings-2026-02-12',
    date: '2026-02-12',
    company: 'Anebulo Pharmaceuticals Inc.',
    ticker: 'ANEB',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'rzlt-earnings-2026-02-12',
    date: '2026-02-12',
    company: 'Rezolute Inc.',
    ticker: 'RZLT',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'bntc-earnings-2026-02-12',
    date: '2026-02-12',
    company: 'Benitec Biopharma Inc.',
    ticker: 'BNTC',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'inbs-earnings-2026-02-12',
    date: '2026-02-12',
    company: 'Intelligent Bio Solutions Inc.',
    ticker: 'INBS',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'alny-earnings-2026-02-12',
    date: '2026-02-12',
    company: 'Alnylam Pharmaceuticals Inc.',
    ticker: 'ALNY',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'grce-earnings-2026-02-12',
    date: '2026-02-12',
    company: 'Grace Therapeutics Inc.',
    ticker: 'GRCE',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'kpti-earnings-2026-02-12',
    date: '2026-02-12',
    company: 'Karyopharm Therapeutics Inc.',
    ticker: 'KPTI',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'ogn-earnings-2026-02-12',
    date: '2026-02-12',
    company: 'Organon & Co.',
    ticker: 'OGN',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'bax-earnings-2026-02-12',
    date: '2026-02-12',
    company: 'Baxter International Inc.',
    ticker: 'BAX',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'brkr-earnings-2026-02-12',
    date: '2026-02-12',
    company: 'Bruker Corporation',
    ticker: 'BRKR',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'agio-earnings-2026-02-12',
    date: '2026-02-12',
    company: 'Agios Pharmaceuticals Inc.',
    ticker: 'AGIO',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'advb-earnings-2026-02-13',
    date: '2026-02-13',
    company: 'Advanced Biomed Inc.',
    ticker: 'ADVB',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'fonr-earnings-2026-02-13',
    date: '2026-02-13',
    company: 'Fonar Corporation',
    ticker: 'FONR',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'edsa-earnings-2026-02-13',
    date: '2026-02-13',
    company: 'Edesa Biotech Inc.',
    ticker: 'EDSA',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'exas-earnings-2026-02-13',
    date: '2026-02-13',
    company: 'Exact Sciences Corporation',
    ticker: 'EXAS',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'ctxr-earnings-2026-02-13',
    date: '2026-02-13',
    company: 'Citius Pharmaceuticals Inc.',
    ticker: 'CTXR',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'ixhl-earnings-2026-02-13',
    date: '2026-02-13',
    company: 'Incannex Healthcare Inc.',
    ticker: 'IXHL',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'xair-earnings-2026-02-13',
    date: '2026-02-13',
    company: 'Beyond Air Inc.',
    ticker: 'XAIR',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'mrna-earnings-2026-02-13',
    date: '2026-02-13',
    company: 'Moderna Inc.',
    ticker: 'MRNA',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'nnvc-earnings-2026-02-17',
    date: '2026-02-17',
    company: 'NanoViricides Inc.',
    ticker: 'NNVC',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'petv-earnings-2026-02-17',
    date: '2026-02-17',
    company: 'PetVivo Holdings Inc.',
    ticker: 'PETV',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'gkos-earnings-2026-02-17',
    date: '2026-02-17',
    company: 'Glaukos Corporation',
    ticker: 'GKOS',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'tcmd-earnings-2026-02-17',
    date: '2026-02-17',
    company: 'Tactile Systems Technology Inc.',
    ticker: 'TCMD',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'bbnx-earnings-2026-02-17',
    date: '2026-02-17',
    company: 'Beta Bionics Inc.',
    ticker: 'BBNX',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'halo-earnings-2026-02-17',
    date: '2026-02-17',
    company: 'Halozyme Therapeutics Inc.',
    ticker: 'HALO',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'atrc-earnings-2026-02-17',
    date: '2026-02-17',
    company: 'AtriCure Inc.',
    ticker: 'ATRC',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'lnai-earnings-2026-02-17',
    date: '2026-02-17',
    company: 'Lunai Bioworks Inc Com',
    ticker: 'LNAI',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'gmab-earnings-2026-02-17',
    date: '2026-02-17',
    company: 'Genmab A/S',
    ticker: 'GMAB',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'lits-earnings-2026-02-17',
    date: '2026-02-17',
    company: 'Lite Strategy Inc.',
    ticker: 'LITS',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'otlk-earnings-2026-02-17',
    date: '2026-02-17',
    company: 'Outlook Therapeutics Inc.',
    ticker: 'OTLK',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'cogt-earnings-2026-02-17',
    date: '2026-02-17',
    company: 'Cogent Biosciences Inc.',
    ticker: 'COGT',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'nmtc-earnings-2026-02-17',
    date: '2026-02-17',
    company: 'NeuroOne Medical Technologies Corporation',
    ticker: 'NMTC',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'ptn-earnings-2026-02-17',
    date: '2026-02-17',
    company: 'Palatin Technologies Inc.',
    ticker: 'PTN',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'neo-earnings-2026-02-17',
    date: '2026-02-17',
    company: 'NeoGenomics Inc.',
    ticker: 'NEO',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'krys-earnings-2026-02-17',
    date: '2026-02-17',
    company: 'Krystal Biotech Inc.',
    ticker: 'KRYS',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'mdt-earnings-2026-02-17',
    date: '2026-02-17',
    company: 'Medtronic plc.',
    ticker: 'MDT',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'idya-earnings-2026-02-17',
    date: '2026-02-17',
    company: 'IDEAYA Biosciences Inc.',
    ticker: 'IDYA',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'bhc-earnings-2026-02-18',
    date: '2026-02-18',
    company: 'Bausch Health Companies Inc.',
    ticker: 'BHC',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'podd-earnings-2026-02-18',
    date: '2026-02-18',
    company: 'Insulet Corporation',
    ticker: 'PODD',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'nams-earnings-2026-02-18',
    date: '2026-02-18',
    company: 'NewAmsterdam Pharma Company N.V.',
    ticker: 'NAMS',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'blco-earnings-2026-02-18',
    date: '2026-02-18',
    company: 'Bausch + Lomb Corporation',
    ticker: 'BLCO',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'prta-earnings-2026-02-19',
    date: '2026-02-19',
    company: 'Prothena Corporation plc',
    ticker: 'PRTA',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'tndm-earnings-2026-02-19',
    date: '2026-02-19',
    company: 'Tandem Diabetes Care Inc.',
    ticker: 'TNDM',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'irtc-earnings-2026-02-19',
    date: '2026-02-19',
    company: 'iRhythm Holdings Inc.',
    ticker: 'IRTC',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'gh-earnings-2026-02-19',
    date: '2026-02-19',
    company: 'Guardant Health Inc.',
    ticker: 'GH',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'icui-earnings-2026-02-19',
    date: '2026-02-19',
    company: 'ICU Medical Inc.',
    ticker: 'ICUI',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'plse-earnings-2026-02-19',
    date: '2026-02-19',
    company: 'Pulse Biosciences Inc',
    ticker: 'PLSE',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'gral-earnings-2026-02-19',
    date: '2026-02-19',
    company: 'GRAIL Inc.',
    ticker: 'GRAL',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'ardx-earnings-2026-02-19',
    date: '2026-02-19',
    company: 'Ardelyx Inc.',
    ticker: 'ARDX',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'ptct-earnings-2026-02-19',
    date: '2026-02-19',
    company: 'PTC Therapeutics Inc.',
    ticker: 'PTCT',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'tvtx-earnings-2026-02-19',
    date: '2026-02-19',
    company: 'Travere Therapeutics Inc.',
    ticker: 'TVTX',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'itgr-earnings-2026-02-19',
    date: '2026-02-19',
    company: 'Integer Holdings Corporation',
    ticker: 'ITGR',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'insm-earnings-2026-02-19',
    date: '2026-02-19',
    company: 'Insmed Incorporated',
    ticker: 'INSM',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'mdgl-earnings-2026-02-19',
    date: '2026-02-19',
    company: 'Madrigal Pharmaceuticals Inc.',
    ticker: 'MDGL',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'prax-earnings-2026-02-19',
    date: '2026-02-19',
    company: 'Praxis Precision Medicines Inc.',
    ticker: 'PRAX',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'sibn-earnings-2026-02-23',
    date: '2026-02-23',
    company: 'SI-BONE Inc.',
    ticker: 'SIBN',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'vir-earnings-2026-02-23',
    date: '2026-02-23',
    company: 'Vir Biotechnology Inc.',
    ticker: 'VIR',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'tars-earnings-2026-02-23',
    date: '2026-02-23',
    company: 'Tarsus Pharmaceuticals Inc.',
    ticker: 'TARS',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'mygn-earnings-2026-02-23',
    date: '2026-02-23',
    company: 'Myriad Genetics Inc.',
    ticker: 'MYGN',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'bmrn-earnings-2026-02-23',
    date: '2026-02-23',
    company: 'BioMarin Pharmaceutical Inc.',
    ticker: 'BMRN',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'glpg-earnings-2026-02-23',
    date: '2026-02-23',
    company: 'Galapagos NV',
    ticker: 'GLPG',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'smmt-earnings-2026-02-23',
    date: '2026-02-23',
    company: 'Summit Therapeutics Inc.',
    ticker: 'SMMT',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'axsm-earnings-2026-02-23',
    date: '2026-02-23',
    company: 'Axsome Therapeutics Inc.',
    ticker: 'AXSM',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'alc-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Alcon Inc.',
    ticker: 'ALC',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'gmed-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Globus Medical Inc. Class A',
    ticker: 'GMED',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'evh-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Evolent Health Inc Class A',
    ticker: 'EVH',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'cort-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Corcept Therapeutics Incorporated',
    ticker: 'CORT',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'jazz-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Jazz Pharmaceuticals plc',
    ticker: 'JAZZ',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'abcl-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'AbCellera Biologics Inc.',
    ticker: 'ABCL',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'atec-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Alphatec Holdings Inc.',
    ticker: 'ATEC',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'ingn-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Inogen Inc',
    ticker: 'INGN',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'tmdx-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'TransMedics Group Inc.',
    ticker: 'TMDX',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'cdna-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'CareDx Inc.',
    ticker: 'CDNA',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'cbll-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'CeriBell Inc.',
    ticker: 'CBLL',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'prct-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'PROCEPT BioRobotics Corporation',
    ticker: 'PRCT',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'supn-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Supernus Pharmaceuticals Inc.',
    ticker: 'SUPN',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'bbio-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'BridgeBio Pharma Inc.',
    ticker: 'BBIO',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'lab-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Standard BioTools Inc.',
    ticker: 'LAB',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'tem-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Tempus AI Inc.',
    ticker: 'TEM',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'cytk-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Cytokinetics Incorporated',
    ticker: 'CYTK',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'pcvx-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Vaxcyte Inc.',
    ticker: 'PCVX',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'dawn-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Day One Biopharmaceuticals Inc.',
    ticker: 'DAWN',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'iova-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Iovance Biotherapeutics Inc.',
    ticker: 'IOVA',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'esta-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Establishment Labs Holdings Inc.',
    ticker: 'ESTA',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'rgen-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Repligen Corporation',
    ticker: 'RGEN',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'hrmy-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Harmony Biosciences Holdings Inc.',
    ticker: 'HRMY',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'apls-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Apellis Pharmaceuticals Inc.',
    ticker: 'APLS',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'arvn-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Arvinas Inc.',
    ticker: 'ARVN',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'axgn-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Axogen Inc.',
    ticker: 'AXGN',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'ahco-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'AdaptHealth Corp.',
    ticker: 'AHCO',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'ofix-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Orthofix Medical Inc.',
    ticker: 'OFIX',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'shc-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Sotera Health Company',
    ticker: 'SHC',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'avns-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Avanos Medical Inc.',
    ticker: 'AVNS',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'elan-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Elanco Animal Health Incorporated',
    ticker: 'ELAN',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'fms-earnings-2026-02-24',
    date: '2026-02-24',
    company: 'Fresenius Medical Care AG',
    ticker: 'FMS',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'cprx-earnings-2026-02-25',
    date: '2026-02-25',
    company: 'Catalyst Pharmaceuticals Inc.',
    ticker: 'CPRX',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'mdxg-earnings-2026-02-25',
    date: '2026-02-25',
    company: 'MiMedx Group Inc',
    ticker: 'MDXG',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'adma-earnings-2026-02-25',
    date: '2026-02-25',
    company: 'ADMA Biologics Inc',
    ticker: 'ADMA',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'acad-earnings-2026-02-25',
    date: '2026-02-25',
    company: 'ACADIA Pharmaceuticals Inc.',
    ticker: 'ACAD',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'srpt-earnings-2026-02-25',
    date: '2026-02-25',
    company: 'Sarepta Therapeutics Inc.',
    ticker: 'SRPT',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'rcus-earnings-2026-02-25',
    date: '2026-02-25',
    company: 'Arcus Biosciences Inc.',
    ticker: 'RCUS',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'slno-earnings-2026-02-25',
    date: '2026-02-25',
    company: 'Soleno Therapeutics Inc.',
    ticker: 'SLNO',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'sdgr-earnings-2026-02-25',
    date: '2026-02-25',
    company: 'Schrodinger Inc.',
    ticker: 'SDGR',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'rxst-earnings-2026-02-25',
    date: '2026-02-25',
    company: 'RxSight Inc.',
    ticker: 'RXST',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'a-earnings-2026-02-25',
    date: '2026-02-25',
    company: 'Agilent Technologies Inc.',
    ticker: 'A',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'lmat-earnings-2026-02-25',
    date: '2026-02-25',
    company: 'LeMaitre Vascular Inc.',
    ticker: 'LMAT',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'vcyt-earnings-2026-02-25',
    date: '2026-02-25',
    company: 'Veracyte Inc.',
    ticker: 'VCYT',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'carl-earnings-2026-02-25',
    date: '2026-02-25',
    company: 'Carlsmed Inc.',
    ticker: 'CARL',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'arqt-earnings-2026-02-25',
    date: '2026-02-25',
    company: 'Arcutis Biotherapeutics Inc.',
    ticker: 'ARQT',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'gdrx-earnings-2026-02-25',
    date: '2026-02-25',
    company: 'GoodRx Holdings Inc.',
    ticker: 'GDRX',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'amrn-earnings-2026-02-25',
    date: '2026-02-25',
    company: 'Amarin Corporation plc',
    ticker: 'AMRN',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'alks-earnings-2026-02-25',
    date: '2026-02-25',
    company: 'Alkermes plc',
    ticker: 'ALKS',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'gern-earnings-2026-02-25',
    date: '2026-02-25',
    company: 'Geron Corporation',
    ticker: 'GERN',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'ions-earnings-2026-02-25',
    date: '2026-02-25',
    company: 'Ionis Pharmaceuticals Inc.',
    ticker: 'IONS',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'imcr-earnings-2026-02-25',
    date: '2026-02-25',
    company: 'Immunocore Holdings plc',
    ticker: 'IMCR',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'uthr-earnings-2026-02-25',
    date: '2026-02-25',
    company: 'United Therapeutics Corporation',
    ticker: 'UTHR',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'rxrx-earnings-2026-02-25',
    date: '2026-02-25',
    company: 'Recursion Pharmaceuticals Inc.',
    ticker: 'RXRX',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'livn-earnings-2026-02-25',
    date: '2026-02-25',
    company: 'LivaNova PLC',
    ticker: 'LIVN',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'ebs-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Emergent BioSolutions Inc.',
    ticker: 'EBS',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'pbyi-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Puma Biotechnology Inc',
    ticker: 'PBYI',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'opk-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Opko Health Inc.',
    ticker: 'OPK',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'crnx-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Crinetics Pharmaceuticals Inc.',
    ticker: 'CRNX',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'ctkb-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Cytek Biosciences Inc.',
    ticker: 'CTKB',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'kids-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'OrthoPediatrics Corp.',
    ticker: 'KIDS',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'masi-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Masimo Corporation',
    ticker: 'MASI',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'ntra-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Natera Inc.',
    ticker: 'NTRA',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'cstl-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Castle Biosciences Inc.',
    ticker: 'CSTL',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'dh-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Definitive Healthcare Corp.',
    ticker: 'DH',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'seer-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Seer Inc.',
    ticker: 'SEER',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'blfs-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'BioLife Solutions Inc.',
    ticker: 'BLFS',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'psnl-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Personalis Inc.',
    ticker: 'PSNL',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'tkno-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Alpha Teknova Inc.',
    ticker: 'TKNO',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'bdsx-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Biodesix Inc.',
    ticker: 'BDSX',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'mdxh-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'MDxHealth SA',
    ticker: 'MDXH',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'pcrx-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Pacira BioSciences Inc.',
    ticker: 'PCRX',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'pgny-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Progyny Inc.',
    ticker: 'PGNY',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'cai-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Caris Life Sciences Inc.',
    ticker: 'CAI',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'phat-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Phathom Pharmaceuticals Inc.',
    ticker: 'PHAT',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'dcth-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Delcath Systems Inc.',
    ticker: 'DCTH',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'vcel-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Vericel Corporation',
    ticker: 'VCEL',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'hrtx-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Heron Therapeutics Inc.',
    ticker: 'HRTX',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'coll-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Collegium Pharmaceutical Inc.',
    ticker: 'COLL',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'mnkd-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'MannKind Corporation',
    ticker: 'MNKD',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'bcrx-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'BioCryst Pharmaceuticals Inc.',
    ticker: 'BCRX',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'anik-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Anika Therapeutics Inc.',
    ticker: 'ANIK',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'lnth-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Lantheus Holdings Inc.',
    ticker: 'LNTH',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'nvcr-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'NovoCure Limited',
    ticker: 'NVCR',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'rytm-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Rhythm Pharmaceuticals Inc.',
    ticker: 'RYTM',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'lgnd-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Ligand Pharmaceuticals Incorporated',
    ticker: 'LGND',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'indv-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Indivior Pharmaceuticals Inc.',
    ticker: 'INDV',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'vtrs-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Viatris Inc.',
    ticker: 'VTRS',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'bfly-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Butterfly Network Inc. Class A',
    ticker: 'BFLY',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'zlab-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Zai Lab Limited',
    ticker: 'ZLAB',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'tfx-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Teleflex Incorporated',
    ticker: 'TFX',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'iart-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Integra LifeSciences Holdings Corporation',
    ticker: 'IART',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'naut-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Nautilus Biotechnology Inc.',
    ticker: 'NAUT',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'prva-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'Privia Health Group Inc.',
    ticker: 'PRVA',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'onc-earnings-2026-02-26',
    date: '2026-02-26',
    company: 'BeOne Medicines Ltd.',
    ticker: 'ONC',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'tmci-earnings-2026-02-27',
    date: '2026-02-27',
    company: 'Treace Medical Concepts Inc.',
    ticker: 'TMCI',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'flgt-earnings-2026-02-27',
    date: '2026-02-27',
    company: 'Fulgent Genetics Inc.',
    ticker: 'FLGT',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'anip-earnings-2026-02-27',
    date: '2026-02-27',
    company: 'ANI Pharmaceuticals Inc.',
    ticker: 'ANIP',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'amrx-earnings-2026-02-27',
    date: '2026-02-27',
    company: 'Amneal Pharmaceuticals Inc.',
    ticker: 'AMRX',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'nuvb-earnings-2026-03-02',
    date: '2026-03-02',
    company: 'Nuvation Bio Inc. Class A',
    ticker: 'NUVB',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'sens-earnings-2026-03-02',
    date: '2026-03-02',
    company: 'Senseonics Holdings Inc.',
    ticker: 'SENS',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'hrow-earnings-2026-03-02',
    date: '2026-03-02',
    company: 'Harrow Inc Com',
    ticker: 'HROW',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'cers-earnings-2026-03-02',
    date: '2026-03-02',
    company: 'Cerus Corporation',
    ticker: 'CERS',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'xers-earnings-2026-03-02',
    date: '2026-03-02',
    company: 'Xeris Biopharma Holdings Inc.',
    ticker: 'XERS',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'cgen-earnings-2026-03-02',
    date: '2026-03-02',
    company: 'Compugen Ltd.',
    ticker: 'CGEN',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'zyme-earnings-2026-03-02',
    date: '2026-03-02',
    company: 'Zymeworks Inc.',
    ticker: 'ZYME',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'eols-earnings-2026-03-03',
    date: '2026-03-03',
    company: 'Evolus Inc.',
    ticker: 'EOLS',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'qsi-earnings-2026-03-03',
    date: '2026-03-03',
    company: 'Quantum-Si Incorporated',
    ticker: 'QSI',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'arct-earnings-2026-03-03',
    date: '2026-03-03',
    company: 'Arcturus Therapeutics Holdings Inc.',
    ticker: 'ARCT',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'srrk-earnings-2026-03-03',
    date: '2026-03-03',
    company: 'Scholar Rock Holding Corporation',
    ticker: 'SRRK',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'mass-earnings-2026-03-03',
    date: '2026-03-03',
    company: '908 Devices Inc.',
    ticker: 'MASS',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'soph-earnings-2026-03-03',
    date: '2026-03-03',
    company: 'SOPHiA GENETICS SA',
    ticker: 'SOPH',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'vstm-earnings-2026-03-04',
    date: '2026-03-04',
    company: 'Verastem Inc.',
    ticker: 'VSTM',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'veev-earnings-2026-03-04',
    date: '2026-03-04',
    company: 'Veeva Systems Inc. Class A',
    ticker: 'VEEV',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'iccc-earnings-2026-03-04',
    date: '2026-03-04',
    company: 'ImmuCell Corporation',
    ticker: 'ICCC',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'ocgn-earnings-2026-03-04',
    date: '2026-03-04',
    company: 'Ocugen, Inc.',
    ticker: 'OCGN',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'coo-earnings-2026-03-05',
    date: '2026-03-05',
    company: 'The Cooper Companies Inc.',
    ticker: 'COO',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'prof-earnings-2026-03-05',
    date: '2026-03-05',
    company: 'Profound Medical Corp.',
    ticker: 'PROF',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'oprx-earnings-2026-03-05',
    date: '2026-03-05',
    company: 'OptimizeRx Corporation',
    ticker: 'OPRX',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'tngx-earnings-2026-03-05',
    date: '2026-03-05',
    company: 'Tango Therapeutics Inc.',
    ticker: 'TNGX',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'hcm-earnings-2026-03-05',
    date: '2026-03-05',
    company: 'HUTCHMED (China) Limited',
    ticker: 'HCM',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'stxs-earnings-2026-03-09',
    date: '2026-03-09',
    company: 'Stereotaxis Inc.',
    ticker: 'STXS',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'bntx-earnings-2026-03-10',
    date: '2026-03-10',
    company: 'BioNTech SE',
    ticker: 'BNTX',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'ctso-earnings-2026-03-11',
    date: '2026-03-11',
    company: 'CytoSorbents Corporation',
    ticker: 'CTSO',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'moln-earnings-2026-03-13',
    date: '2026-03-13',
    company: 'Molecular Partners AG',
    ticker: 'MOLN',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'acxp-earnings-2026-03-13',
    date: '2026-03-13',
    company: 'Acurx Pharmaceuticals Inc.',
    ticker: 'ACXP',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'catx-earnings-2026-03-16',
    date: '2026-03-16',
    company: 'Isoray. (DE)',
    ticker: 'CATX',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'hqy-earnings-2026-03-17',
    date: '2026-03-17',
    company: 'HealthEquity Inc.',
    ticker: 'HQY',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'stim-earnings-2026-03-17',
    date: '2026-03-17',
    company: 'Neuronetics Inc.',
    ticker: 'STIM',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'htfl-earnings-2026-03-18',
    date: '2026-03-18',
    company: 'Heartflow, Inc.',
    ticker: 'HTFL',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'tnon-earnings-2026-03-19',
    date: '2026-03-19',
    company: 'Tenon Medical Inc.',
    ticker: 'TNON',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'abvx-earnings-2026-03-23',
    date: '2026-03-23',
    company: 'Abivax SA',
    ticker: 'ABVX',
    drug: 'Q4 2025 Earnings',
    indication: 'After Market Close',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },
  {
    id: 'ipha-earnings-2026-03-26',
    date: '2026-03-26',
    company: 'Innate Pharma S.A.',
    ticker: 'IPHA',
    drug: 'Q4 2025 Earnings',
    indication: 'Before Market Open',
    type: 'Earnings',
    appType: '',
    ta: 'Earnings',
    phase: '',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
  },

  // ═══════════════════════════════════════════════════
  // PHASE READOUTS 2026
  // ═══════════════════════════════════════════════════
  {
    id: 'avdl-lumryzrevitalyz-2026-02-11',
    date: '2026-02-11',
    company: 'Avadel Pharmaceuticals plc',
    ticker: 'AVDL',
    drug: 'LUMRYZ - (REVITALYZ)',
    indication: 'Idiopathic hypersomnia',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT06525077',
  },
  {
    id: 'anro-alto101-2026-02-11',
    date: '2026-02-11',
    company: 'Alto Neuroscience Inc.',
    ticker: 'ANRO',
    drug: 'ALTO-101',
    indication: 'Schizophrenia',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06502964',
  },
  {
    id: 'gnpx-reqorsaimmunogenethe-2026-02-11',
    date: '2026-02-11',
    company: 'Genprex Inc.',
    ticker: 'GNPX',
    drug: 'REQORSA Immunogene Therapy (quratusugene ozeplasmid) - (Acclaim-3)',
    indication: 'Extensive-stage small cell lung cancer (ES-SCLC)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT05703971',
  },
  {
    id: 'imcr-brenetafuspimcf106cp-2026-02-11',
    date: '2026-02-11',
    company: 'Immunocore Holdings plc',
    ticker: 'IMCR',
    drug: 'Brenetafusp (IMC-F106C) - (PRAME-A02)',
    indication: 'Solid tumors',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT04262466',
  },
  {
    id: 'ktta-pas004-2026-02-11',
    date: '2026-02-11',
    company: 'Pasithea Therapeutics Corp.',
    ticker: 'KTTA',
    drug: 'PAS-004',
    indication: 'Cancer Patients',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT06299839',
  },
  {
    id: 'rgnx-rgx202affinityduchen-2026-02-11',
    date: '2026-02-11',
    company: 'REGENXBIO Inc.',
    ticker: 'RGNX',
    drug: 'RGX-202 - (AFFINITY DUCHENNE)',
    indication: 'Duchenne Muscular Dystrophy (DMD)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT05693142',
  },
  {
    id: 'xncr-xmab819-2026-02-11',
    date: '2026-02-11',
    company: 'Xencor Inc.',
    ticker: 'XNCR',
    drug: 'XmAb819',
    indication: 'Renal Cell Carcinoma (RCC)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT05433142',
  },
  {
    id: 'bmy-opdivoantipd1ca01707-2026-02-16',
    date: '2026-02-16',
    company: 'Bristol-Myers Squibb Company',
    ticker: 'BMY',
    drug: 'Opdivo (anti-PD1) - (CA017-078)',
    indication: 'Peri-Adjuvant Immunotherapy in High-Risk Muscle-Invasive Urothelial Cancer',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT03661320',
  },
  {
    id: 'nvs-zigakibartbion1301be-2026-02-19',
    date: '2026-02-19',
    company: 'Novartis AG',
    ticker: 'NVS',
    drug: 'Zigakibart (BION-1301) - (BEYOND)',
    indication: 'IgA nephropathy',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT05852938',
  },
  {
    id: 'nvs-pelacarsenlpahorizon-2026-02-26',
    date: '2026-02-26',
    company: 'Novartis AG',
    ticker: 'NVS',
    drug: 'pelacarsen - (Lp(a)HORIZON)',
    indication: 'Cardiovascular disease',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT04023552',
  },
  {
    id: 'bmy-prmt5i-2026-02-26',
    date: '2026-02-26',
    company: 'Bristol-Myers Squibb Company',
    ticker: 'BMY',
    drug: 'PRMT5i',
    indication: 'Advanced solid tumors',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT06130553',
  },
  {
    id: 'bmy-opdivoantipd1checkma-2026-02-27',
    date: '2026-02-27',
    company: 'Bristol-Myers Squibb Company',
    ticker: 'BMY',
    drug: 'Opdivo (anti-PD1) - (CheckMate -9DX)',
    indication: 'Adjuvant Hepatocellular Carcinoma (HCC)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT03383458',
  },
  {
    id: 'adct-zynlontaloncastuxima-2026-02-28',
    date: '2026-02-28',
    company: 'ADC Therapeutics SA',
    ticker: 'ADCT',
    drug: 'ZYNLONTA (Loncastuximab Tesirine) and RITUXAN (rituximab) - (LOTIS-5)',
    indication: 'Diffuse Large B-Cell Lymphoma (DLBCL)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT04384484',
  },
  {
    id: 'vrdn-vrdn003reveal1-2026-03-01',
    date: '2026-03-01',
    company: 'Viridian Therapeutics Inc.',
    ticker: 'VRDN',
    drug: 'VRDN-003 - (REVEAL-1)',
    indication: 'Active and Chronic Moderate-to-Severe Thyroid Eye Disease',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT06625411',
  },
  {
    id: 'atai-vls01elumina-2026-03-01',
    date: '2026-03-01',
    company: 'AtaiBeckley Inc.',
    ticker: 'ATAI',
    drug: 'VLS-01 - (Elumina)',
    indication: 'Treatment Resistant Depression',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06524830',
  },
  {
    id: 'azn-tozorakimabmiranda-2026-03-02',
    date: '2026-03-02',
    company: 'AstraZeneca PLC',
    ticker: 'AZN',
    drug: 'tozorakimab - (MIRANDA)',
    indication: 'Chronic Obstructive Pulmonary Disease (COPD)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06040086',
  },
  {
    id: 'aard-ard101hero-2026-03-11',
    date: '2026-03-11',
    company: 'Aardvark Therapeutics Inc.',
    ticker: 'AARD',
    drug: 'ARD-101 - (HERO)',
    indication: 'Prader-Willi Syndrome',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT06828861',
  },
  {
    id: 'kpti-selinexorxportmf034s-2026-03-11',
    date: '2026-03-11',
    company: 'Karyopharm Therapeutics Inc.',
    ticker: 'KPTI',
    drug: 'Selinexor (XPORT-MF-034) - (SENTRY)',
    indication: 'JAK inhibitor (JAKi) naïve myelofibrosis versus ruxolitinib alone',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT04562389',
  },
  {
    id: 'kpti-xpovioselinexorpomal-2026-03-11',
    date: '2026-03-11',
    company: 'Karyopharm Therapeutics Inc.',
    ticker: 'KPTI',
    drug: 'XPOVIO (selinexor), Pomalidomide and Dexamethasone - (EMN29/XPORT-MM-031)',
    indication: 'Multiple Myeloma',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT05028348',
  },
  {
    id: 'krys-kb803iolite-2026-03-11',
    date: '2026-03-11',
    company: 'Krystal Biotech Inc.',
    ticker: 'KRYS',
    drug: 'KB803 - (IOLITE)',
    indication: 'Corneal abrasions in Dystrophic Epidermolysis Bullosa (DEB) patients',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT07016750',
  },
  {
    id: 'lly-orforglipronachieve4-2026-03-11',
    date: '2026-03-11',
    company: 'Eli Lilly and Company',
    ticker: 'LLY',
    drug: 'Orforglipron - (ACHIEVE-4)',
    indication: 'Type 2 Diabetes',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT05803421',
  },
  {
    id: 'avtx-avtx009antiil1mablot-2026-03-11',
    date: '2026-03-11',
    company: 'Avalo Therapeutics Inc.',
    ticker: 'AVTX',
    drug: 'AVTX-009 (anti-IL-1β mAb) - (LOTUS)',
    indication: 'Hidradenitis suppurativa (HS)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06603077',
  },
  {
    id: 'nsrx-ns002-2026-03-11',
    date: '2026-03-11',
    company: 'Nasus Pharma Ltd.',
    ticker: 'NSRX',
    drug: 'NS002',
    indication: 'Anaphylaxis',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT07228325',
  },
  {
    id: 'aciu-18faci15916petinsynu-2026-03-11',
    date: '2026-03-11',
    company: 'AC Immune SA',
    ticker: 'ACIU',
    drug: '[18F]ACI-15916 PET in α-synucleinopathies',
    indication: 'Parkinson\'s disease (PD)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT06891703',
  },
  {
    id: 'bcyc-bicycletoxinconjugat-2026-03-11',
    date: '2026-03-11',
    company: 'Bicycle Therapeutics plc',
    ticker: 'BCYC',
    drug: 'Bicycle Toxin Conjugates zelenectide pevedotin (BT8009) - (Duravelo-2)',
    indication: 'Solid tumors',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT04561362',
  },
  {
    id: 'rlyb-rlyb116-2026-03-11',
    date: '2026-03-11',
    company: 'Rallybio Corporation',
    ticker: 'RLYB',
    drug: 'RLYB116',
    indication: 'Immune platelet transfusion refractoriness (PTR), refractory antiphospholipid syndrome (APS)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT06797375',
  },
  {
    id: 'sepn-sep631-2026-03-11',
    date: '2026-03-11',
    company: 'Septerna Inc.',
    ticker: 'SEPN',
    drug: 'SEP-631',
    indication: 'Mast Cell Diseases',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT07069036',
  },
  {
    id: 'mltx-nanobodysonelokimabv-2026-03-27',
    date: '2026-03-27',
    company: 'MoonLake Immunotherapeutics',
    ticker: 'MLTX',
    drug: 'Nanobody (sonelokimab) - (VELA-TEEN)',
    indication: 'Hidradenitis suppurativa (HS)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT06768671',
  },
  {
    id: 'hrmy-epx100argus-2026-04-01',
    date: '2026-04-01',
    company: 'Harmony Biosciences Holdings Inc.',
    ticker: 'HRMY',
    drug: 'EPX-100 - (ARGUS)',
    indication: 'Dravet Syndrome',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT04462770',
  },
  {
    id: 'vrdn-vrdn003reveal2-2026-04-01',
    date: '2026-04-01',
    company: 'Viridian Therapeutics Inc.',
    ticker: 'VRDN',
    drug: 'VRDN-003 - (REVEAL-2)',
    indication: 'Chronic Thyroid Eye Disease (TED)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT06625398',
  },
  {
    id: 'abvx-obefazimodabtect-2026-04-11',
    date: '2026-04-11',
    company: 'Abivax SA',
    ticker: 'ABVX',
    drug: 'Obefazimod - (ABTECT)',
    indication: 'Ulcerative colitis',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT05535946',
  },
  {
    id: 'azn-eplontersencardiottr-2026-04-11',
    date: '2026-04-11',
    company: 'AstraZeneca PLC',
    ticker: 'AZN',
    drug: 'eplontersen - (CARDIO-TTRansform)',
    indication: 'Transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) in adults.',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT04136171',
  },
  {
    id: 'ions-eplontersencardiottr-2026-04-11',
    date: '2026-04-11',
    company: 'Ionis Pharmaceuticals Inc.',
    ticker: 'IONS',
    drug: 'eplontersen - (CARDIO-TTRansform)',
    indication: 'Transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) in adults.',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT04136171',
  },
  {
    id: 'ions-akceattrlrxcardiottr-2026-04-11',
    date: '2026-04-11',
    company: 'Ionis Pharmaceuticals Inc.',
    ticker: 'IONS',
    drug: 'AKCEA-TTR-LRx - (CARDIO-TTRansform)',
    indication: 'ATTR cardiomyopathy',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT04136171',
  },
  {
    id: 'lpcn-lpcn1154oralbrexanol-2026-04-11',
    date: '2026-04-11',
    company: 'Lipocine Inc.',
    ticker: 'LPCN',
    drug: 'LPCN 1154 (oral brexanolone)',
    indication: 'Postpartum Depression',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT06979544',
  },
  {
    id: 'ntla-lonvoguranziclumeran-2026-04-11',
    date: '2026-04-11',
    company: 'Intellia Therapeutics Inc.',
    ticker: 'NTLA',
    drug: 'Lonvoguran ziclumeran (lonvo-z, formerly NTLA-2002) - (HAELO)',
    indication: 'Hereditary angioedema (HAE)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT06634420',
  },
  {
    id: 'cntb-rademikibartseabreez-2026-04-11',
    date: '2026-04-11',
    company: 'Connect Biopharma Holdings Limited',
    ticker: 'CNTB',
    drug: 'Rademikibart - (Seabreeze STAT Asthma)',
    indication: 'Asthma',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06940141',
  },
  {
    id: 'kpti-selinexorxportmf044s-2026-04-11',
    date: '2026-04-11',
    company: 'Karyopharm Therapeutics Inc.',
    ticker: 'KPTI',
    drug: 'Selinexor (XPORT-MF-044) - (SENTRY-2)',
    indication: 'JAK inhibitor-naïve MF and moderate thrombocytopenia',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT05980806',
  },
  {
    id: 'ocs-ocs01diamond1-2026-04-11',
    date: '2026-04-11',
    company: 'Oculis Holding AG',
    ticker: 'OCS',
    drug: 'OCS-01 - (DIAMOND-1)',
    indication: 'Diabetic macular edema (DME)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT05066997',
  },
  {
    id: 'bntx-bnt323db1303-2026-04-11',
    date: '2026-04-11',
    company: 'BioNTech SE',
    ticker: 'BNTX',
    drug: 'BNT323/DB-1303',
    indication: 'Human Epidermal Growth Factor Receptor 2 (HER2) expressing advanced endometrial cancer',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT05150691',
  },
  {
    id: 'immp-imp761-2026-04-11',
    date: '2026-04-11',
    company: 'Immutep Limited',
    ticker: 'IMMP',
    drug: 'IMP761',
    indication: 'Autoimmune diseases',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT06637865',
  },
  {
    id: 'mrna-trivalentmrna1403nov-2026-04-14',
    date: '2026-04-14',
    company: 'Moderna Inc.',
    ticker: 'MRNA',
    drug: 'Trivalent (mRNA-1403) - (Nova 301)',
    indication: 'Norovirus',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT05992935',
  },
  {
    id: 'lsta-certepetidelsta1bols-2026-04-18',
    date: '2026-04-18',
    company: 'Lisata Therapeutics Inc.',
    ticker: 'LSTA',
    drug: 'Certepetide (LSTA1) - (BOLSTER)',
    indication: 'Intrahepatic Cholangiocarcinoma',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT05712356',
  },
  {
    id: 'lsta-lsta1incombinationwi-2026-04-18',
    date: '2026-04-18',
    company: 'Lisata Therapeutics Inc.',
    ticker: 'LSTA',
    drug: 'LSTA1 in combination with SoC chemotherapy - (BOLSTER)',
    indication: 'Solid Tumors',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT05712356',
  },
  {
    id: 'ocul-axpaxliotxtkisol1-2026-04-29',
    date: '2026-04-29',
    company: 'Ocular Therapeutix Inc.',
    ticker: 'OCUL',
    drug: 'AXPAXLI (OTX-TKI) - (SOL-1)',
    indication: 'Wet Age-related Macular Degeneration (AMD)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT06223958',
  },
  {
    id: 'azn-imfinzidurvalumabvol-2026-04-30',
    date: '2026-04-30',
    company: 'AstraZeneca PLC',
    ticker: 'AZN',
    drug: 'Imfinzi (durvalumab) - (VOLGA)',
    indication: 'Cisplatin-Ineligible Muscle-Invasive Bladder Cancer (MIBC)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT04960709',
  },
  {
    id: 'tnya-tn401ridge1-2026-05-01',
    date: '2026-05-01',
    company: 'Tenaya Therapeutics Inc.',
    ticker: 'TNYA',
    drug: 'TN-401 - (RIDGE-1)',
    indication: 'Arrhythmogenic Right Ventricular Cardiomyopathy',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT06228924',
  },
  {
    id: 'bntx-bnt323db1303-2026-05-11',
    date: '2026-05-11',
    company: 'BioNTech SE',
    ticker: 'BNTX',
    drug: 'BNT323/DB-1303',
    indication: 'HR+ HER2-low metastatic breast cancer',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT06018337',
  },
  {
    id: 'exel-xl092withatezolizuma-2026-05-11',
    date: '2026-05-11',
    company: 'Exelixis Inc.',
    ticker: 'EXEL',
    drug: 'XL092 with atezolizumab - (STELLAR-303)',
    indication: 'Colorectal Cancer (CRC)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT05425940',
  },
  {
    id: 'alt-pemvidutidereclaim-2026-05-11',
    date: '2026-05-11',
    company: 'Altimmune Inc.',
    ticker: 'ALT',
    drug: 'Pemvidutide - (RECLAIM)',
    indication: 'Alcohol Use Disorder (AUD)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06987513',
  },
  {
    id: 'bmea-bmf650glp131-2026-05-11',
    date: '2026-05-11',
    company: 'Biomea Fusion Inc.',
    ticker: 'BMEA',
    drug: 'BMF-650 (GLP-131)',
    indication: 'Obesity',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT07223216',
  },
  {
    id: 'glue-mrt2359-2026-05-11',
    date: '2026-05-11',
    company: 'Monte Rosa Therapeutics Inc.',
    ticker: 'GLUE',
    drug: 'MRT-2359',
    indication: 'MYC-driven solid tumors',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT05546268',
  },
  {
    id: 'biib-ionismaptrxisis81490-2026-05-14',
    date: '2026-05-14',
    company: 'Biogen Inc.',
    ticker: 'BIIB',
    drug: 'IONIS-MAPTRx (ISIS 814907; BIIB080) - (CELIA)',
    indication: 'Alzheimer\'s disease',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT05399888',
  },
  {
    id: 'ions-ionismaptrxisis81490-2026-05-14',
    date: '2026-05-14',
    company: 'Ionis Pharmaceuticals Inc.',
    ticker: 'IONS',
    drug: 'IONIS-MAPTRx (ISIS 814907; BIIB080) - (CELIA)',
    indication: 'Alzheimer\'s disease',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT05399888',
  },
  {
    id: 'mbx-mbx4291-2026-05-30',
    date: '2026-05-30',
    company: 'MBX Biosciences Inc.',
    ticker: 'MBX',
    drug: 'MBX 4291',
    indication: 'Obesity & co-morbidities',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT07142707',
  },
  {
    id: 'gnlx-olvimulogenenanivaci-2026-06-11',
    date: '2026-06-11',
    company: 'Genelux Corporation',
    ticker: 'GNLX',
    drug: 'Olvimulogene Nanivacirepvec (Olvi-Vec) - (OnPrime/GOG-3076)',
    indication: 'Platinum-Resistant or Refractory Ovarian Cancer',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT05281471',
  },
  {
    id: 'rvmd-daraxonrasibrmc6236r-2026-06-11',
    date: '2026-06-11',
    company: 'Revolution Medicines Inc - Ordinary Shares',
    ticker: 'RVMD',
    drug: 'Daraxonrasib (RMC-6236) - (RASolute 302)',
    indication: 'Metastatic pancreatic ductal adenocarcinoma (PDAC)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT06625320',
  },
  {
    id: 'bivi-bezisterimne3107addr-2026-06-11',
    date: '2026-06-11',
    company: 'BioVie Inc.',
    ticker: 'BIVI',
    drug: 'Bezisterim (NE3107) - (ADDRESS-LC)',
    indication: 'Long COVID',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06847191',
  },
  {
    id: 'ewtx-edg7500cirrushcm-2026-06-11',
    date: '2026-06-11',
    company: 'Edgewise Therapeutics Inc.',
    ticker: 'EWTX',
    drug: 'EDG-7500 - (CIRRUS-HCM)',
    indication: 'Hypertrophic Cardiomyopathy (HCM)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06347159',
  },
  {
    id: 'mirm-volixibatvistas-2026-06-11',
    date: '2026-06-11',
    company: 'Mirum Pharmaceuticals Inc.',
    ticker: 'MIRM',
    drug: 'Volixibat - (VISTAS)',
    indication: 'Primary sclerosing cholangitis',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT04663308',
  },
  {
    id: 'qttb-bempikibartsignalaa-2026-06-11',
    date: '2026-06-11',
    company: 'Q32 Bio Inc.',
    ticker: 'QTTB',
    drug: 'Bempikibart - (SIGNAL-AA)',
    indication: 'Alopecia areata (AA)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06018428',
  },
  {
    id: 'syre-spy001spy002spy003sk-2026-06-11',
    date: '2026-06-11',
    company: 'Spyre Therapeutics Inc.',
    ticker: 'SYRE',
    drug: 'SPY001, SPY002, SPY003 - (SKYLINE)',
    indication: 'Crohn\'s disease',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT07012395',
  },
  {
    id: 'zbio-obexelimabsunstone-2026-06-11',
    date: '2026-06-11',
    company: 'Zenas BioPharma Inc.',
    ticker: 'ZBIO',
    drug: 'Obexelimab - (SunStone)',
    indication: 'Systemic Lupus Erythematosus (SLE)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06559163',
  },
  {
    id: 'aciu-aci24antiabetavaccin-2026-06-11',
    date: '2026-06-11',
    company: 'AC Immune SA',
    ticker: 'ACIU',
    drug: 'ACI-24 (anti-Abeta vaccine) - (ABATE)',
    indication: 'Down syndrome',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT05462106',
  },
  {
    id: 'aciu-aci24antiabetavaccin-2026-06-11',
    date: '2026-06-11',
    company: 'AC Immune SA',
    ticker: 'ACIU',
    drug: 'ACI-24 (anti-Abeta vaccine)',
    indication: 'Alzheimer\'s disease-like characteristics in individuals with Down syndrome',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT05462106',
  },
  {
    id: 'brns-vtp1000avalon-2026-06-11',
    date: '2026-06-11',
    company: 'Barinthus Biotherapeutics plc American Depositary Shares',
    ticker: 'BRNS',
    drug: 'VTP-1000 - (AVALON)',
    indication: 'Celiac disease',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT06310291',
  },
  {
    id: 'clyd-vtp1000avalon-2026-06-11',
    date: '2026-06-11',
    company: 'Clyde Resources Inc',
    ticker: 'CLYD',
    drug: 'VTP-1000 - (AVALON)',
    indication: 'Celiac disease',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT06310291',
  },
  {
    id: 'sion-sion451galicaftorsio-2026-06-11',
    date: '2026-06-11',
    company: 'Sionna Therapeutics Inc.',
    ticker: 'SION',
    drug: 'SION-451 + Galicaftor (SION-2222)',
    indication: 'Healthy volunteers',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT07035990',
  },
  {
    id: 'tak-aci24antiabetavaccin-2026-06-11',
    date: '2026-06-11',
    company: 'Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)',
    ticker: 'TAK',
    drug: 'ACI-24 (anti-Abeta vaccine) - (ABATE)',
    indication: 'Down syndrome',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT05462106',
  },
  {
    id: 'wve-wven531forward53-2026-06-27',
    date: '2026-06-27',
    company: 'Wave Life Sciences Ltd.',
    ticker: 'WVE',
    drug: 'WVE-N531 - (FORWARD-53)',
    indication: 'Duchenne muscular dystrophy (DMD) in boys',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT04906460',
  },
  {
    id: 'azn-durvalumabincombinat-2026-06-30',
    date: '2026-06-30',
    company: 'AstraZeneca PLC',
    ticker: 'AZN',
    drug: 'Durvalumab in combination with monalizumab or oleclumab - (PACIFIC-9)',
    indication: 'Stage III non-small cell lung cancer (NSCLC)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT05221840',
  },
  {
    id: 'celc-gedatolisibwithfulve-2026-06-30',
    date: '2026-06-30',
    company: 'Celcuity Inc.',
    ticker: 'CELC',
    drug: 'Gedatolisib with Fulvestrant - (VIKTORIA-1)',
    indication: 'HR+/HER2- advanced breast cancer',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT05501886',
  },
  {
    id: 'ipha-durvalumabincombinat-2026-06-30',
    date: '2026-06-30',
    company: 'Innate Pharma S.A.',
    ticker: 'IPHA',
    drug: 'Durvalumab in combination with monalizumab or oleclumab - (PACIFIC-9)',
    indication: 'Stage III non-small cell lung cancer (NSCLC)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT05221840',
  },
  {
    id: 'jnj-nbtxr3nanoray312-2026-06-30',
    date: '2026-06-30',
    company: 'Johnson & Johnson',
    ticker: 'JNJ',
    drug: 'NBTXR3 - (NANORAY-312)',
    indication: 'Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT04892173',
  },
  {
    id: 'lian-nbtxr3withcetuximabn-2026-06-30',
    date: '2026-06-30',
    company: 'LianBio',
    ticker: 'LIAN',
    drug: 'NBTXR3 with Cetuximab - (NANORAY-312)',
    indication: 'Head and Neck Cancer',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT04892173',
  },
  {
    id: 'nbtx-nbtxr3withcetuximabn-2026-06-30',
    date: '2026-06-30',
    company: 'Nanobiotix S.A.',
    ticker: 'NBTX',
    drug: 'NBTXR3 with Cetuximab - (NANORAY-312)',
    indication: 'Head and Neck Cancer',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT04892173',
  },
  {
    id: 'dnth-dnth103momentum-2026-06-30',
    date: '2026-06-30',
    company: 'Dianthus Therapeutics Inc.',
    ticker: 'DNTH',
    drug: 'DNTH103 - (MoMeNtum)',
    indication: 'Multifocal Motor Neuropathy (MMN)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06537999',
  },
  {
    id: 'engn-detalimogenevoraplas-2026-06-30',
    date: '2026-06-30',
    company: 'enGene Holdings Inc.',
    ticker: 'ENGN',
    drug: 'Detalimogene voraplasmid (EG-70) - (LEGEND)',
    indication: 'BCG-unresponsive non-muscle invasive bladder cancer (NMIBC)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT04752722',
  },
  {
    id: 'lgvn-laromestrocellomecel-2026-06-30',
    date: '2026-06-30',
    company: 'Longeveron Inc.',
    ticker: 'LGVN',
    drug: 'Laromestrocel (lomecel-B) - (ELPIS II)',
    indication: 'Hypoplastic Left Heart Syndrome',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT04925024',
  },
  {
    id: 'clls-ucart22balli01-2026-06-30',
    date: '2026-06-30',
    company: 'Cellectis S.A.',
    ticker: 'CLLS',
    drug: 'UCART22 - (BALLI-01)',
    indication: 'Relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT04150497',
  },
  {
    id: 'howl-wtx124-2026-07-01',
    date: '2026-07-01',
    company: 'Werewolf Therapeutics Inc.',
    ticker: 'HOWL',
    drug: 'WTX-124',
    indication: 'Solid Tumors',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT05479812',
  },
  {
    id: 'rare-gtx102aspire-2026-07-11',
    date: '2026-07-11',
    company: 'Ultragenyx Pharmaceutical Inc.',
    ticker: 'RARE',
    drug: 'GTX-102 - (Aspire)',
    indication: 'Angelman Syndrome',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT06617429',
  },
  {
    id: 'sngx-hybryteflash2-2026-07-11',
    date: '2026-07-11',
    company: 'Soligenix Inc.',
    ticker: 'SNGX',
    drug: 'HyBryte - (FLASH2)',
    indication: 'Cutaneous T-Cell Lymphoma',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT06470451',
  },
  {
    id: 'dwtx-halneuronhaltcinphal-2026-07-11',
    date: '2026-07-11',
    company: 'Dogwood Therapeutics Inc.',
    ticker: 'DWTX',
    drug: 'Halneuron - (HALT-CINP / HAL-CINP-203)',
    indication: 'Chemotherapy-induced Neuropathic Pain',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06848348',
  },
  {
    id: 'sion-sion719precisioncf-2026-07-11',
    date: '2026-07-11',
    company: 'Sionna Therapeutics Inc.',
    ticker: 'SION',
    drug: 'SION-719 - (PreciSION CF)',
    indication: 'Cystic Fibrosis',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT07108153',
  },
  {
    id: 'pyxs-pyx201101micvo-2026-07-11',
    date: '2026-07-11',
    company: 'Pyxis Oncology Inc.',
    ticker: 'PYXS',
    drug: 'PYX-201-101 - (MICVO)',
    indication: 'Solid tumors',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT05720117',
  },
  {
    id: 'canf-namodenosoncf102222p-2026-07-15',
    date: '2026-07-15',
    company: 'Can-Fite Biopharma Ltd American Depositary Shares each representing two (2)',
    ticker: 'CANF',
    drug: 'Namodenoson - (CF102-222PC)',
    indication: 'Pancreatic Cancer',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06387342',
  },
  {
    id: 'jazz-ziiherazanidatamabhr-2026-07-31',
    date: '2026-07-31',
    company: 'Jazz Pharmaceuticals plc',
    ticker: 'JAZZ',
    drug: 'Ziihera (zanidatamab-hrii) - (HERIZON-GEA-01)',
    indication: 'First-line HER2-positive gastroesophageal adenocarcinoma (GEA)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT05152147',
  },
  {
    id: 'onc-ziiherazanidatamabhr-2026-07-31',
    date: '2026-07-31',
    company: 'BeOne Medicines Ltd.',
    ticker: 'ONC',
    drug: 'Ziihera (zanidatamab-hrii) - (HERIZON-GEA-01)',
    indication: 'First-line HER2-positive gastroesophageal adenocarcinoma (GEA)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT05152147',
  },
  {
    id: 'zyme-ziiherazanidatamabhr-2026-07-31',
    date: '2026-07-31',
    company: 'Zymeworks Inc.',
    ticker: 'ZYME',
    drug: 'Ziihera (zanidatamab-hrii) - (HERIZON-GEA-01)',
    indication: 'First-line HER2-positive gastroesophageal adenocarcinoma (GEA)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT05152147',
  },
  {
    id: 'bcyc-bt5528andopdivonivol-2026-07-31',
    date: '2026-07-31',
    company: 'Bicycle Therapeutics plc',
    ticker: 'BCYC',
    drug: 'BT5528 and OPDIVO (nivolumab)',
    indication: 'Solid tumors',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT04180371',
  },
  {
    id: 'kpti-xpovioselinexorxport-2026-08-11',
    date: '2026-08-11',
    company: 'Karyopharm Therapeutics Inc.',
    ticker: 'KPTI',
    drug: 'XPOVIO (selinexor) - (XPORT-EC-042)',
    indication: 'TP53 wild-type advanced or recurrent endometrial cancer',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT05611931',
  },
  {
    id: 'phvs-deucrictibantphvs416-2026-08-11',
    date: '2026-08-11',
    company: 'Pharvaris N.V.',
    ticker: 'PHVS',
    drug: 'Deucrictibant (PHVS416) - (CHAPTER-3)',
    indication: 'Hereditary angioedema - prophylactic use',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT06669754',
  },
  {
    id: 'rna-delpacibartetedesira-2026-08-11',
    date: '2026-08-11',
    company: 'Avidity Biosciences Inc.',
    ticker: 'RNA',
    drug: 'Delpacibart Etedesiran (del-desiran) - (HARBOR)',
    indication: 'Myotonic dystrophy type 1 (DM1)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT06411288',
  },
  {
    id: 'slgl-sgt610patidegib-2026-08-11',
    date: '2026-08-11',
    company: 'Sol-Gel Technologies Ltd.',
    ticker: 'SLGL',
    drug: 'SGT-610 (patidegib)',
    indication: 'Gorlin syndrome',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT06050122',
  },
  {
    id: 'bcyc-bt7480withnivolumab-2026-08-11',
    date: '2026-08-11',
    company: 'Bicycle Therapeutics plc',
    ticker: 'BCYC',
    drug: 'BT7480 with nivolumab',
    indication: 'Oncology, solid tumors',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT05163041',
  },
  {
    id: 'kura-ziftomenibincombinat-2026-08-11',
    date: '2026-08-11',
    company: 'Kura Oncology Inc.',
    ticker: 'KURA',
    drug: 'ziftomenib in combination with gilteritinib (KOMET-008)',
    indication: 'FLAG-IDA or LDAC for the treatment of NPM1-mutant or KMT2A-rearranged acute myeloid leukemia (AML)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT06001788',
  },
  {
    id: 'kytx-kyv101-2026-08-11',
    date: '2026-08-11',
    company: 'Kyverna Therapeutics Inc.',
    ticker: 'KYTX',
    drug: 'KYV-101',
    indication: 'Refractory Lupus Nephritis',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT05938725',
  },
  {
    id: 'ncna-nuc7738nutide701inco-2026-08-11',
    date: '2026-08-11',
    company: 'NuCana plc',
    ticker: 'NCNA',
    drug: 'NUC-7738 (NuTide:701)  in combination with pembrolizumab',
    indication: 'Melanoma',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT03829254',
  },
  {
    id: 'acrv-acr2316-2026-08-12',
    date: '2026-08-12',
    company: 'Acrivon Therapeutics Inc.',
    ticker: 'ACRV',
    drug: 'ACR-2316',
    indication: 'Dual WEE1 and PKMYT1 inhibitor, Solid tumors',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT06667141',
  },
  {
    id: 'mrk-rezatapoptpc14586pyn-2026-08-15',
    date: '2026-08-15',
    company: 'Merck & Company Inc.',
    ticker: 'MRK',
    drug: 'Rezatapopt (PC14586) - (PYNNACLE)',
    indication: 'Solid tumors',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT04585750',
  },
  {
    id: 'pmvp-rezatapoptpc14586pyn-2026-08-15',
    date: '2026-08-15',
    company: 'PMV Pharmaceuticals Inc.',
    ticker: 'PMVP',
    drug: 'Rezatapopt (PC14586) - (PYNNACLE)',
    indication: 'Solid tumors',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT04585750',
  },
  {
    id: 'azn-com902azd2936artemid-2026-08-18',
    date: '2026-08-18',
    company: 'AstraZeneca PLC',
    ticker: 'AZN',
    drug: 'COM902 (AZD2936) - (ARTEMIDE-01)',
    indication: 'Non-small cell lung cancer (NSCLC)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT04995523',
  },
  {
    id: 'cgen-com902azd2936artemid-2026-08-18',
    date: '2026-08-18',
    company: 'Compugen Ltd.',
    ticker: 'CGEN',
    drug: 'COM902 (AZD2936) - (ARTEMIDE-01)',
    indication: 'Non-small cell lung cancer (NSCLC)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT04995523',
  },
  {
    id: 'hcm-orpathyssavolitiniba-2026-08-30',
    date: '2026-08-30',
    company: 'HUTCHMED (China) Limited',
    ticker: 'HCM',
    drug: 'ORPATHYS (savolitinib) and TAGRISSO (osimertinib) - (SANOVO)',
    indication: 'First-line treatment in certain non-small cell lung cancer (NSCLC)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT05009836',
  },
  {
    id: 'vstm-vs6766anddefactinibr-2026-08-31',
    date: '2026-08-31',
    company: 'Verastem Inc.',
    ticker: 'VSTM',
    drug: 'VS-6766 and defactinib - (RAMP 205)',
    indication: 'Metastatic pancreatic cancer',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT05669482',
  },
  {
    id: 'nvs-monjuvitafasitamabfr-2026-09-01',
    date: '2026-09-01',
    company: 'Novartis AG',
    ticker: 'NVS',
    drug: 'MONJUVI (tafasitamab) - (frontMIND)',
    indication: 'Diffuse Large B-Cell Lymphoma (DLBCL)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT04824092',
  },
  {
    id: 'hcm-sovleplenibchinatria-2026-09-11',
    date: '2026-09-11',
    company: 'HUTCHMED (China) Limited',
    ticker: 'HCM',
    drug: 'Sovleplenib - (China trial)',
    indication: 'Warm antibody autoimmune hemolytic anemia (wAIHA)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT05535933',
  },
  {
    id: 'hcm-sovleplenibeslim02-2026-09-11',
    date: '2026-09-11',
    company: 'HUTCHMED (China) Limited',
    ticker: 'HCM',
    drug: 'Sovleplenib - (ESLIM-02)',
    indication: 'Warm antibody autoimmune hemolytic anemia (wAIHA)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT05535933',
  },
  {
    id: 'bhvn-taldefgrobepalfa-2026-09-11',
    date: '2026-09-11',
    company: 'Biohaven Ltd.',
    ticker: 'BHVN',
    drug: 'Taldefgrobep alfa',
    indication: 'Obesity',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT07281495',
  },
  {
    id: 'ewtx-sevasemtenedg5509gra-2026-09-11',
    date: '2026-09-11',
    company: 'Edgewise Therapeutics Inc.',
    ticker: 'EWTX',
    drug: 'Sevasemten (EDG-5509) - (GRAND CANYON)',
    indication: 'Becker and Duchenne muscular dystrophy',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT05291091',
  },
  {
    id: 'nvs-tour006spirited-2026-09-11',
    date: '2026-09-11',
    company: 'Novartis AG',
    ticker: 'NVS',
    drug: 'TOUR006 - (spiriTED)',
    indication: 'Thyroid Eye Disease (TED)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06088979',
  },
  {
    id: 'orka-orka001everlasta-2026-09-11',
    date: '2026-09-11',
    company: 'Oruka Therapeutics Inc.',
    ticker: 'ORKA',
    drug: 'ORKA-001 - (EVERLAST-A)',
    indication: 'Moderate-to-severe plaque psoriasis',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT07090330',
  },
  {
    id: 'pcsa-ngccapecitabinepcs64-2026-09-11',
    date: '2026-09-11',
    company: 'Processa Pharmaceuticals Inc.',
    ticker: 'PCSA',
    drug: 'NGC-Capecitabine (PCS6422)',
    indication: 'Breast cancer',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06568692',
  },
  {
    id: 'pfe-taldefgrobepalfa-2026-09-11',
    date: '2026-09-11',
    company: 'Pfizer Inc.',
    ticker: 'PFE',
    drug: 'Taldefgrobep alfa',
    indication: 'Obesity',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT07281495',
  },
  {
    id: 'sln-divesiransln124sanre-2026-09-11',
    date: '2026-09-11',
    company: 'Silence Therapeutics Plc',
    ticker: 'SLN',
    drug: 'Divesiran (SLN124) - (SANRECO)',
    indication: 'Polycythemia Vera',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT05499013',
  },
  {
    id: 'sndx-niktimvoaxatilimabcs-2026-09-11',
    date: '2026-09-11',
    company: 'Syndax Pharmaceuticals Inc.',
    ticker: 'SNDX',
    drug: 'Niktimvo (axatilimab-csfr) - (MAXPIRe)',
    indication: 'Idiopathic pulmonary fibrosis (IPF)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06132256',
  },
  {
    id: 'trml-tour006spirited-2026-09-11',
    date: '2026-09-11',
    company: 'Tourmaline Bio Inc.',
    ticker: 'TRML',
    drug: 'TOUR006 - (spiriTED)',
    indication: 'Thyroid Eye Disease (TED)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06088979',
  },
  {
    id: 'dtil-ecur506otchope-2026-09-11',
    date: '2026-09-11',
    company: 'Precision BioSciences Inc.',
    ticker: 'DTIL',
    drug: 'ECUR-506 - (OTC-HOPE)',
    indication: 'Ornithine Transcarbamylase (OTC) Deficiency',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT06255782',
  },
  {
    id: 'iron-disc0974-2026-09-11',
    date: '2026-09-11',
    company: 'Disc Medicine Inc.',
    ticker: 'IRON',
    drug: 'DISC-0974',
    indication: 'Myelofibrosis (MF) patients with anemia',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT05320198',
  },
  {
    id: 'oric-enozertiniboric114-2026-09-11',
    date: '2026-09-11',
    company: 'Oric Pharmaceuticals Inc.',
    ticker: 'ORIC',
    drug: 'Enozertinib (ORIC-114)',
    indication: 'Tumors - EGFR/HER2 Exon 20 Inhibitor, 1L NSCLC',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT05315700',
  },
  {
    id: 'azn-datopotamabderuxteca-2026-09-30',
    date: '2026-09-30',
    company: 'AstraZeneca PLC',
    ticker: 'AZN',
    drug: 'Datopotamab deruxtecan with or without osimertinib - (TROPION-Lung15)',
    indication: 'Metastatic Non-small Cell Lung Cancer (NSCLC)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT06417814',
  },
  {
    id: 'bmrn-bmn351-2026-09-30',
    date: '2026-09-30',
    company: 'BioMarin Pharmaceutical Inc.',
    ticker: 'BMRN',
    drug: 'BMN 351',
    indication: 'Duchenne Muscular Dystrophy (DMD)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT06280209',
  },
  {
    id: 'qure-amt162-2026-09-30',
    date: '2026-09-30',
    company: 'uniQure N.V.',
    ticker: 'QURE',
    drug: 'AMT-162',
    indication: 'SOD1-ALS',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT06100276',
  },
  {
    id: 'eypt-duravyueyp1901lucia-2026-10-11',
    date: '2026-10-11',
    company: 'EyePoint Inc.',
    ticker: 'EYPT',
    drug: 'DURAVYU (EYP-1901) - (LUCIA)',
    indication: 'wet AMD',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT06683742',
  },
  {
    id: 'lly-jaypircapirtobrutini-2026-10-11',
    date: '2026-10-11',
    company: 'Eli Lilly and Company',
    ticker: 'LLY',
    drug: 'Jaypirca (pirtobrutinib) - (BRUIN CLL-322)',
    indication: 'Chronic Lymphocytic Leukemia',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT04965493',
  },
  {
    id: 'tenx-tnx103orallevosimend-2026-10-11',
    date: '2026-10-11',
    company: 'Tenax Therapeutics Inc.',
    ticker: 'TENX',
    drug: 'TNX-103 (oral levosimendan) - (LEVEL)',
    indication: 'Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT05983250',
  },
  {
    id: 'abos-acu193altitudead-2026-10-11',
    date: '2026-10-11',
    company: 'Acumen Pharmaceuticals Inc.',
    ticker: 'ABOS',
    drug: 'ACU193 - (ALTITUDE-AD)',
    indication: 'Early Alzheimer\'s disease',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06335173',
  },
  {
    id: 'rapp-rap219-2026-10-11',
    date: '2026-10-11',
    company: 'Rapport Therapeutics Inc.',
    ticker: 'RAPP',
    drug: 'RAP-219',
    indication: 'Bipolar mania',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT07046494',
  },
  {
    id: 'rgnx-surabgenelomparvovec-2026-10-11',
    date: '2026-10-11',
    company: 'REGENXBIO Inc.',
    ticker: 'RGNX',
    drug: 'Surabgene lomparvovec (sura-vec, ABBV-RGX-314) - (ASCENT)',
    indication: 'Wet age-related macular degeneration (wet AMD)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT05407636',
  },
  {
    id: 'rna-delpacibartbraxlosir-2026-10-11',
    date: '2026-10-11',
    company: 'Avidity Biosciences Inc.',
    ticker: 'RNA',
    drug: 'Delpacibart braxlosiran (del-brax) - (FORTITUDE)',
    indication: 'Facioscapulohumeral Muscular Dystrophy (FSHD)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT05747924',
  },
  {
    id: 'bcrx-bcx17725-2026-10-11',
    date: '2026-10-11',
    company: 'BioCryst Pharmaceuticals Inc.',
    ticker: 'BCRX',
    drug: 'BCX17725',
    indication: 'Netherton syndrome',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT06539507',
  },
  {
    id: 'bmy-milvexianlibrexiaaf-2026-10-31',
    date: '2026-10-31',
    company: 'Bristol-Myers Squibb Company',
    ticker: 'BMY',
    drug: 'Milvexian - (Librexia AF)',
    indication: 'Prevention of stroke in patients with atrial fibrillation',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT05757869',
  },
  {
    id: 'jnj-milvexianlibrexiaaf-2026-10-31',
    date: '2026-10-31',
    company: 'Johnson & Johnson',
    ticker: 'JNJ',
    drug: 'Milvexian - (Librexia AF)',
    indication: 'Prevention of stroke in patients with atrial fibrillation',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT05757869',
  },
  {
    id: 'acrv-acr368-2026-10-31',
    date: '2026-10-31',
    company: 'Acrivon Therapeutics Inc.',
    ticker: 'ACRV',
    drug: 'ACR-368',
    indication: 'Platinum-resistant ovarian,(PROC) endometrial, and urothelial cancers',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT05548296',
  },
  {
    id: 'adag-muzastotugadg126comb-2026-10-31',
    date: '2026-10-31',
    company: 'Adagene Inc.',
    ticker: 'ADAG',
    drug: 'muzastotug (ADG126) combined with KEYTRUDA  (pembrolizumab) - (ADG126-P001/KEYNOTE-C98)',
    indication: 'Solid tumors',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT05405595',
  },
  {
    id: 'annx-anx007archerii-2026-10-31',
    date: '2026-10-31',
    company: 'Annexon Inc.',
    ticker: 'ANNX',
    drug: 'ANX007 - (ARCHER-II)',
    indication: 'Geographic atrophy',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06510816',
  },
  {
    id: 'syre-spy072skywayrdbasket-2026-10-31',
    date: '2026-10-31',
    company: 'Spyre Therapeutics Inc.',
    ticker: 'SYRE',
    drug: 'SPY072 - (SKYWAY-RD, basket study)',
    indication: 'Rheumatoid arthritis (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT07148414',
  },
  {
    id: 'sdgr-sgr3515-2026-10-31',
    date: '2026-10-31',
    company: 'Schrodinger Inc.',
    ticker: 'SDGR',
    drug: 'SGR-3515',
    indication: 'Solid tumors',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT06463340',
  },
  {
    id: 'bmy-milvexianlibrexiastr-2026-11-11',
    date: '2026-11-11',
    company: 'Bristol-Myers Squibb Company',
    ticker: 'BMY',
    drug: 'Milvexian - (Librexia STROKE)',
    indication: 'Stroke prevention in patients after an acute ischemic stroke or high-risk transient ischemic attack',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT05702034',
  },
  {
    id: 'crvs-soquelitinibcpi818-2026-11-11',
    date: '2026-11-11',
    company: 'Corvus Pharmaceuticals Inc.',
    ticker: 'CRVS',
    drug: 'Soquelitinib  - (CPI-818)',
    indication: 'Peripheral T-cell lymphoma (PTCL)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT06561048',
  },
  {
    id: 'jnj-milvexianlibrexiastr-2026-11-11',
    date: '2026-11-11',
    company: 'Johnson & Johnson',
    ticker: 'JNJ',
    drug: 'Milvexian - (Librexia STROKE)',
    indication: 'Stroke prevention in patients after an acute ischemic stroke or high-risk transient ischemic attack',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT05702034',
  },
  {
    id: 'lly-orforglipronattainos-2026-11-11',
    date: '2026-11-11',
    company: 'Eli Lilly and Company',
    ticker: 'LLY',
    drug: 'Orforglipron - (ATTAIN-OSA)',
    indication: 'Obstructive Sleep Apnea (OSA), Hypertension, OA Knee Pain',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT06649045',
  },
  {
    id: 'bntx-autogenecevumeranbnt-2026-11-11',
    date: '2026-11-11',
    company: 'BioNTech SE',
    ticker: 'BNTX',
    drug: 'Autogene cevumeran (BNT122/RO7198457)',
    indication: 'Adjuvant ctDNA+ stage II (high risk) / stage III colorectal cancer (CRC)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT04486378',
  },
  {
    id: 'crdf-crdf004-2026-11-11',
    date: '2026-11-11',
    company: 'Cardiff Oncology Inc.',
    ticker: 'CRDF',
    drug: 'CRDF-004',
    indication: 'Metastatic colorectal cancer (mCRC)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06106308',
  },
  {
    id: 'eltx-eli002amplify7p-2026-11-11',
    date: '2026-11-11',
    company: 'Elicio Therapeutics Inc.',
    ticker: 'ELTX',
    drug: 'ELI-002 - (AMPLIFY-7P)',
    indication: 'mKRAS-driven cancers',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT05726864',
  },
  {
    id: 'pfe-crdf004-2026-11-11',
    date: '2026-11-11',
    company: 'Pfizer Inc.',
    ticker: 'PFE',
    drug: 'CRDF-004',
    indication: 'Metastatic colorectal cancer (mCRC)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06106308',
  },
  {
    id: 'abcl-abcl575-2026-11-11',
    date: '2026-11-11',
    company: 'AbCellera Biologics Inc.',
    ticker: 'ABCL',
    drug: 'ABCL575',
    indication: 'Atopic Dermatitis',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT07108894',
  },
  {
    id: 'skye-nimacimabcbeyond-2026-11-20',
    date: '2026-11-20',
    company: 'Skye Bioscience Inc.',
    ticker: 'SKYE',
    drug: 'Nimacimab - (CBeyond)',
    indication: 'Obesity',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06577090',
  },
  {
    id: 'zntl-azenosertibznc3zejul-2026-12-01',
    date: '2026-12-01',
    company: 'Zentalis Pharmaceuticals Inc.',
    ticker: 'ZNTL',
    drug: 'Azenosertib (ZN-c3) + ZEJULA (Niraparib) - (DENALI)',
    indication: 'Platinum Resistant  High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT05128825',
  },
  {
    id: 'nvo-zaltenibartoms906-2026-12-11',
    date: '2026-12-11',
    company: 'Novo Nordisk A/S',
    ticker: 'NVO',
    drug: 'Zaltenibart  - (OMS906)',
    indication: 'Paroxysmal nocturnal hemoglobinuria (PNH)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT06298955',
  },
  {
    id: 'omer-zaltenibartoms906-2026-12-11',
    date: '2026-12-11',
    company: 'Omeros Corporation',
    ticker: 'OMER',
    drug: 'Zaltenibart  - (OMS906)',
    indication: 'Paroxysmal nocturnal hemoglobinuria (PNH)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT06298955',
  },
  {
    id: 'anro-alto300-2026-12-11',
    date: '2026-12-11',
    company: 'Alto Neuroscience Inc.',
    ticker: 'ANRO',
    drug: 'ALTO-300',
    indication: 'Major Depressive Disorder (MDD)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT05922878',
  },
  {
    id: 'clsd-surabgenelomparvovec-2026-12-11',
    date: '2026-12-11',
    company: 'Clearside Biomedical Inc.',
    ticker: 'CLSD',
    drug: 'Surabgene lomparvovec (sura-vec, ABBV-RGX-314) - (ATMOSPHERE)',
    indication: 'Wet AMD',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT04704921',
  },
  {
    id: 'clym-budoprutugtnt119-2026-12-11',
    date: '2026-12-11',
    company: 'Climb Bio Inc.',
    ticker: 'CLYM',
    drug: 'Budoprutug (TNT119)',
    indication: 'Systemic lupus erythematosus',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06570434',
  },
  {
    id: 'dmac-rinvecalinasealfadm1-2026-12-11',
    date: '2026-12-11',
    company: 'DiaMedica Therapeutics Inc.',
    ticker: 'DMAC',
    drug: 'Rinvecalinase Alfa (DM199) - (ReMEDy2)',
    indication: 'Acute ischaemic stroke (AIS)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT05065216',
  },
  {
    id: 'mgtx-aav2haqp1aquax2-2026-12-11',
    date: '2026-12-11',
    company: 'MeiraGTx Holdings plc',
    ticker: 'MGTX',
    drug: 'AAV2-hAQP1 - (AQUAx2)',
    indication: 'Xerostomia',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT05926765',
  },
  {
    id: 'rgnx-surabgenelomparvovec-2026-12-11',
    date: '2026-12-11',
    company: 'REGENXBIO Inc.',
    ticker: 'RGNX',
    drug: 'Surabgene lomparvovec (sura-vec, ABBV-RGX-314) - (ATMOSPHERE)',
    indication: 'Wet AMD',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT04704921',
  },
  {
    id: 'roiv-mosliciguatphocus-2026-12-11',
    date: '2026-12-11',
    company: 'Roivant Sciences Ltd.',
    ticker: 'ROIV',
    drug: 'Mosliciguat - (PHocus)',
    indication: 'Pulmonary hypertension associated with interstitial lung disease (PH-ILD)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT06635850',
  },
  {
    id: 'apge-apg279apg777apg990-2026-12-11',
    date: '2026-12-11',
    company: 'Apogee Therapeutics Inc.',
    ticker: 'APGE',
    drug: 'APG279 (APG777+APG990)',
    indication: 'Atopic dermatitis (AD)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT07027527',
  },
  {
    id: 'bmy-ryz101action1-2026-12-11',
    date: '2026-12-11',
    company: 'Bristol-Myers Squibb Company',
    ticker: 'BMY',
    drug: 'RYZ101 - (ACTION-1)',
    indication: 'Gastroenteropancreatic neuroendocrine tumors',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT05477576',
  },
  {
    id: 'cgem-cln978outracesle-2026-12-11',
    date: '2026-12-11',
    company: 'Cullinan Therapeutics Inc.',
    ticker: 'CGEM',
    drug: 'CLN-978 - (OUTRACE SLE)',
    indication: 'Systemic Lupus Erythematosus (SLE)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT06613360',
  },
  {
    id: 'fdmt-4d710aerow-2026-12-11',
    date: '2026-12-11',
    company: '4D Molecular Therapeutics Inc.',
    ticker: 'FDMT',
    drug: '4D-710 - (AEROW)',
    indication: 'Cystic fibrosis',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT05248230',
  },
  {
    id: 'immx-nxc201hbi10101nexica-2026-12-11',
    date: '2026-12-11',
    company: 'Immix Biopharma Inc.',
    ticker: 'IMMX',
    drug: 'NXC-201 (HBI10101) - (NEXICART-2)',
    indication: 'Relapsed/refractory AL Amyloidosis',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT06097832',
  },
  {
    id: 'lxeo-lx2020heroicpkp2-2026-12-11',
    date: '2026-12-11',
    company: 'Lexeo Therapeutics, Inc.',
    ticker: 'LXEO',
    drug: 'LX2020 - (HEROIC-PKP2)',
    indication: 'PKP2-ACM',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT06109181',
  },
  {
    id: 'nxtc-lncb74-2026-12-11',
    date: '2026-12-11',
    company: 'NextCure Inc.',
    ticker: 'NXTC',
    drug: 'LNCB74',
    indication: 'B7-H4 expressing cancers',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT06774963',
  },
  {
    id: 'pmn-pmn310precisead-2026-12-11',
    date: '2026-12-11',
    company: 'ProMIS Neurosciences Inc.',
    ticker: 'PMN',
    drug: 'PMN310 - (PRECISE-AD)',
    indication: 'Alzheimer\'s disease (AD)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT06750432',
  },
  {
    id: 'zyme-zw191-2026-12-11',
    date: '2026-12-11',
    company: 'Zymeworks Inc.',
    ticker: 'ZYME',
    drug: 'ZW191',
    indication: 'Non-small cell lung cancer, endometrial cancer, and triple-negative breast cancer',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT06555744',
  },
  {
    id: 'advm-ixovecixoberogenesor-2026-12-22',
    date: '2026-12-22',
    company: 'Adverum Biotechnologies Inc.',
    ticker: 'ADVM',
    drug: 'Ixo-vec (ixoberogene soroparvovec, ADVM-022)  - (ARTEMIS)',
    indication: 'Wet age-related macular degeneration (AMD)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT06856577',
  },
  {
    id: 'nthi-neo10001-2026-12-30',
    date: '2026-12-30',
    company: 'NeOnc Technologies Holdings Inc.',
    ticker: 'NTHI',
    drug: 'NEO100-01',
    indication: 'Glioblastoma (GBM)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT05023018',
  },
  {
    id: 'tcrx-tsc202a0201-2026-12-30',
    date: '2026-12-30',
    company: 'TScan Therapeutics Inc.',
    ticker: 'TCRX',
    drug: 'TSC-202-A0201',
    indication: 'Human papillomavirus 16 (HPV16)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT05973487',
  },
  {
    id: 'vir-tobevibartandelebsir-2026-12-31',
    date: '2026-12-31',
    company: 'Vir Biotechnology Inc.',
    ticker: 'VIR',
    drug: 'Tobevibart and Elebsiran - (ECLIPSE-1)',
    indication: 'Chronic hepatitis delta infection',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 3 Readout',
    phase: 'Phase 3',
    designations: [],
    prob: 0,
    tier: 'TIER_1',
    signals: {},
    notes: 'NCT06903338',
  },
  {
    id: 'mnov-mn001tipelukastnatg2-2026-12-31',
    date: '2026-12-31',
    company: 'MediciNova Inc.',
    ticker: 'MNOV',
    drug: 'MN-001 (Tipelukast) - (NATG-202)',
    indication: 'Non-alcoholic fatty liver disease (NAFLD) with Type 2 Diabetes Mellitus and Hypertriglyceridemia',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT05464784',
  },
  {
    id: 'pbyi-alisertibpumaali4201-2026-12-31',
    date: '2026-12-31',
    company: 'Puma Biotechnology Inc',
    ticker: 'PBYI',
    drug: 'Alisertib - (PUMA-ALI-4201) - (ALISCA-Lung1)',
    indication: 'Small Cell Lung Cancer (SCLC)',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 2 Readout',
    phase: 'Phase 2',
    designations: [],
    prob: 0,
    tier: 'TIER_2',
    signals: {},
    notes: 'NCT04085315',
  },
  {
    id: 'gild-ide397trodelvysacitu-2026-12-31',
    date: '2026-12-31',
    company: 'Gilead Sciences Inc.',
    ticker: 'GILD',
    drug: 'IDE397 + Trodelvy (sacituzumab-govitecan-hziy)',
    indication: 'MTAP-Deletion Bladder Cancer',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT04794699',
  },
  {
    id: 'idya-ide397trodelvysacitu-2026-12-31',
    date: '2026-12-31',
    company: 'IDEAYA Biosciences Inc.',
    ticker: 'IDYA',
    drug: 'IDE397 + Trodelvy (sacituzumab-govitecan-hziy)',
    indication: 'MTAP-Deletion Bladder Cancer',
    type: 'READOUT',
    appType: '',
    ta: 'Phase 1 Readout',
    phase: 'Phase 1',
    designations: [],
    prob: 0,
    tier: 'TIER_3',
    signals: {},
    notes: 'NCT04794699',
  },
];
